ID Ca21chr5 standard; DNA; UNK; 1190928 BP.
XX
AC unknown;
XX
DE 1190928 nucleotides
XX
FH Key Location/Qualifiers
FH
FT CDS complement(857705..858178)
FT /gene="orf19.1105"
FT /Ca19Contig="Ca19-10093|38..511"
FT /synonym="orf19.8701, IPF26202.1, IPF15959.2, Contig4-
FT 2815_0001, orf6.753, CA0170"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS 856605..856859
FT /gene="orf19.1105.2"
FT /Ca19Contig="Ca19-10093|complement(1357..1611)"
FT /synonym="IPF17002.3, IPF15957.2, Contig4-2815_0003,
FT CA0171"
FT /remarks="Regulator of sorbose utilization; putative GPI-
FT anchor; predicted helix-loop helix domain; hyphal induced;
FT induced during cell wall regeneration; shows colony
FT morphology-related gene regulation by Ssn6p; transcription
FT activated by Tbf1p"
FT CDS complement(855473..855730)
FT /gene="orf19.1105.3"
FT /Ca19Contig="Ca19-10093|join(2486..2725,2725..3198)"
FT /synonym="IPF26207.1, IPF20047.1, Contig4-2815_0006,
FT orf6.2981"
FT /remarks="ORF Predicted by Annotation Working Group"
FT CDS complement(848594..850948)
FT /gene="orf19.1106"
FT /Ca19Contig="Ca19-10093|7172..9622"
FT /synonym="orf19.8703, IPF26190.1, IPF6342.1, Contig4-
FT 2815_0016, Contig4-2815_0017, orf6.2982, CA1458"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; shows
FT Mob2p-dependent hyphal regulation; fluconazole-induced"
FT CDS complement(847077..847685)
FT /gene="orf19.1107"
FT /Ca19Contig="Ca19-10093|10531..11139"
FT /synonym="orf19.8704, IPF26199.1, IPF6340.2, Contig4-
FT 2815_0018, orf6.2983, CA1459"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 846299..846907
FT /gene="orf19.1108"
FT /Ca19Contig="Ca19-10093|complement(11309..11917)"
FT /synonym="orf19.8705, IPF26200.1, IPF6339.1, Contig4-
FT 2815_0019, orf6.2984, CA1460"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT caspofungin repressed; regulated by Gcn2p and Gcn4p"
FT CDS 845545..845937
FT /gene="orf19.1109"
FT /Ca19Contig="Ca19-10093|complement(12279..12671)"
FT /synonym="orf19.8706, IPF26205.1, IPF6338.1, Contig4-
FT 2815_0021, orf6.2985, CA1461"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 844153..845136
FT /gene="orf19.1110"
FT /Ca19Contig="Ca19-10093|complement(13080..14072)"
FT /synonym="orf19.8707, IPF6335.2, IPF6334.3, Contig4-
FT 2815_0022, Contig4-2815_0023, orf6.2986, CA1462"
FT /remarks="Thiamine pyrophosphokinase, phosphorylates
FT thiamine to produce the coenzyme thiamine pyrophosphate
FT (thiamine diphosphate); active as a homodimer"
FT CDS complement(843253..843951)
FT /gene="orf19.1111"
FT /Ca19Contig="Ca19-10093|14265..14963"
FT /synonym="orf19.8708, IPF18669.1, IPF6333.3, Contig4-
FT 2766_0002, orf6.2987, orf6.3463, CA1804"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(840609..842903)
FT /gene="orf19.1112"
FT /Ca19Contig="Ca19-10093|15313..17607"
FT /synonym="orf19.8709, IPF26191.1, IPF6332.2, Contig4-
FT 2766_0004, Contig4-2766_0006, orf6.3464, CA1805"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT fungal-specific (no human or murine homolog)"
FT CDS complement(839369..840136)
FT /gene="orf19.1113"
FT /Ca19Contig="Ca19-10093|18080..18847"
FT /synonym="orf19.8710, IPF26197.1, IPF6329.2, Contig4-
FT 2766_0009, orf6.3465, CA1806"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS join(838594..838637,838755..839178)
FT /gene="orf19.1114"
FT /Ca19Contig="Ca19-10093|complement(join(19579..19622,19038.
FT .19461))"
FT /synonym="orf19.8711, IPF26204.1, IPF6328.2, Contig4-
FT 2766_0010, Contig4-2766_0011, orf6.3466, CA1807"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 837684..838256
FT /gene="orf19.1115"
FT /Ca19Contig="Ca19-10093|complement(19960..20691)"
FT /synonym="orf19.8712, IPF26196.1, IPF6326.2, Contig4-
FT 2766_0012, orf6.3467, CA1808"
FT /remarks="Putative guanylate kinase; identified in
FT extracts from biofilm and planktonic cells"
FT CDS complement(836270..836896)
FT /gene="orf19.1116"
FT /Ca19Contig="Ca19-10093|21320..21946"
FT /synonym="orf19.8713, IPF26198.1, IPF6325.2, Contig4-
FT 2766_0014, orf6.3468, CA1809"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS complement(833953..835092)
FT /gene="orf19.1117"
FT /Ca19Contig="Ca19-10093|23124..24263"
FT /synonym="orf19.8714, IPF19255.2, IPF6323.2, Contig4-
FT 2766_0017, orf6.3469, orf6.485, CA1810"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT similar to Candida boidinii formate dehydrogenase"
FT CDS complement(830668..833547)
FT /gene="orf19.1119"
FT /Ca19Contig="Ca19-10093|24669..27548"
FT /synonym="orf19.8717, IPF13881.3, IPF6321.2, orf6.3471,
FT orf6.487, orf6.488, CA1811"
FT /remarks="Transcription is regulated by Mig1p "
FT CDS 829537..829962
FT /gene="orf19.1120"
FT /Ca19Contig="Ca19-10093|complement(28254..28679)"
FT /synonym="orf19.8718, IPF26203.1, IPF13879.2, Contig4-
FT 1995_0001, orf6.3472, CA1812"
FT /remarks="Induced by mating factor in MTLa/MTLa opaque
FT cells; greater mRNA abundance observed in a cyr1
FT homozygous null mutant than in wild type; filament
FT induced; regulated by Nrg1p, Rfg1p, Tup1p; possibly
FT spurious ORF (AWG prediction)"
FT CDS 825621..826442
FT /gene="orf19.1121"
FT /Ca19Contig="Ca19-10093|complement(31774..32595)"
FT /synonym="orf19.8719, IPF2329.1, IPF13871.1, Contig4-
FT 1915_0003, Contig4-1995_0007, Contig4-1995_0008,
FT orf6.1196, orf6.3473, CA1813"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 824264..825106
FT /gene="orf19.1122"
FT /Ca19Contig="Ca19-10093|complement(33110..33952)"
FT /synonym="orf19.8720, IPF2328.2, IPF13870.2, Contig4-
FT 1915_0004, orf6.1197, orf6.3474, CA0360"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT transcription is induced in response to alpha pheromone in
FT SpiderM medium"
FT CDS complement(823514..823867)
FT /gene="orf19.1123"
FT /Ca19Contig="Ca19-10093|34349..34702"
FT /synonym="orf19.8721, IPF26211.1, IPF29575.1, orf6.1198"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(822548..823432)
FT /gene="orf19.1124"
FT /Ca19Contig="Ca19-10093|34784..35668"
FT /synonym="orf19.8722, IPF26195.1, IPF2326.2, orf6.1199,
FT CA0361"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(821336..822235)
FT /gene="orf19.1124.2"
FT /Ca19Contig="Ca19-10093|35981..36202"
FT /synonym="IPF26215.1, IPF2323.3, IPF2322.2, CA4284,
FT orf19.6682"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 913853..915208
FT /gene="orf19.1279"
FT /Ca19Contig="Ca19-10105|complement(1933..3288)"
FT /synonym="orf19.8866, IPF26045.1, IPF16312.2, Contig4-
FT 2808_0002, orf6.874, CA0213"
FT /remarks="Protein similar to S. cerevisiae Cds1p;
FT transposon mutation affects filamentous growth"
FT CDS complement(912081..912410)
FT /gene="orf19.1280"
FT /Ca19Contig="Ca19-10105|4731..5060"
FT /synonym="orf19.8867, IPF10374.1, IPF29514.1, Contig4-
FT 2808_0003, orf6.4245, CA2367"
FT /remarks="Putative translation initiation factor;
FT flucytosine induced; genes encoding ribosomal subunits,
FT translation factors, and tRNA synthetases are
FT downregulated upon phagocytosis by murine macrophage"
FT CDS complement(910882..911547)
FT /gene="orf19.1281"
FT /Ca19Contig="Ca19-10105|5594..6259"
FT /synonym="orf19.8868, IPF26047.1, IPF10373.1, Contig4-
FT 2808_0006, orf6.4244, CA2366"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(909613..909921)
FT /gene="orf19.1282"
FT /Ca19Contig="Ca19-10105|7220..7528"
FT /synonym="orf19.8869, IPF26050.1, IPF10371.2, Contig4-
FT 2808_0007, orf6.4243, CA2365"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(902168..909145)
FT /gene="orf19.1283"
FT /Ca19Contig="Ca19-10105|7996..14973"
FT /synonym="orf19.8870, IPF19757.1, IPF29511.1, Contig4-
FT 2808_0008, Contig4-2808_0009, Contig4-2808_0011,
FT orf6.4242, CA2364"
FT /remarks="Protein described as cell cycle checkpoint
FT protein; RNA abundance regulated by tyrosol and cell
FT density"
FT CDS 899327..902122
FT /gene="orf19.1285"
FT /Ca19Contig="Ca19-10105|complement(15019..17814)"
FT /synonym="orf19.8872, IPF26042.1, IPF10590.2, orf6.4240,
FT CA2363"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(896484..896840)
FT /gene="orf19.1286"
FT /Ca19Contig="Ca19-10105|20301..20657"
FT /synonym="orf19.8873, IPF26049.1, IPF29513.1, orf6.4239"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 891567..892709
FT /gene="orf19.1287"
FT /Ca19Contig="Ca19-10105|complement(24432..25574)"
FT /synonym="orf19.8874, IPF26046.1, IPF10595.1, orf6.4238,
FT CA2362"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS 313356..315341
FT /gene="orf19.1926"
FT /Ca19Contig="Ca19-10137|complement(1..1164)"
FT /synonym="orf19.9482, orf19.11606, IPF25372.1, IPF15112.2,
FT IPF23122.1, IPF18736.1, Contig4-2911_0020, orf6.1277,
FT orf6.2618, CA0395, orf19.4129"
FT /remarks="Putative zinc cluster protein; expression is
FT repressed by Sfu1p under high-iron conditions"
FT CDS complement(311136..311744)
FT /gene="orf19.1927"
FT /Ca19Contig="Ca19-10137|2770..3378"
FT /synonym="orf19.9483, IPF19001.2, IPF15109.2, Contig4-
FT 2699_0002, orf6.1278, CA0396"
FT /remarks="Protein described as similar to RNase MRP RNA
FT binding protein; ciclopirox olamine induced"
FT CDS 308765..310897
FT /gene="orf19.1930"
FT /Ca19Contig="Ca19-10137|complement(3617..5749)"
FT /synonym="orf19.9486, orf6.5607, orf6.1281, IPF25358.1,
FT IPF15107.3, Contig4-2699_0003, Contig4-2699_0004, CA0397"
FT /remarks="Protein similar to ferric reductase Fre10p;
FT expression greater in low iron; negatively regulated by
FT Sfu1p; ciclopirox olamine, flucytosine induced;
FT amphotericin B repressed; transcription is positively
FT regulated by Tbf1p"
FT CDS 303390..305522
FT /gene="orf19.1932"
FT /Ca19Contig="Ca19-10137|complement(8992..11124)"
FT /synonym="orf19.9488, orf6.292, IPF9791.2, IPF19355.2,
FT Contig4-2583_0010, orf6.5606, CA3363"
FT /remarks="Similar to ferric reductase, C-terminal region;
FT expression greater in low iron; transcription is
FT negatively regulated by Sfu1p; ciclopirox olamine induced;
FT shows colony morphology-related gene regulation by Ssn6p"
FT CDS 299586..301436
FT /gene="orf19.1933"
FT /Ca19Contig="Ca19-10137|complement(13078..14928)"
FT /synonym="orf19.9489, IPF9789.2, IPF19133.2, Contig4-
FT 2583_0014, Contig4-2583_0017, orf6.5605, orf6.829, CA3362"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 297649..299112
FT /gene="orf19.1934"
FT /Ca19Contig="Ca19-10137|complement(15402..16865)"
FT /synonym="orf19.9490, IPF25371.1, IPF9787.2, Contig4-
FT 2583_0018, Contig4-2985_0001, orf6.5604, orf6.830, CA0197"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT repressed upon high-level peroxide stress"
FT CDS 296722..297168
FT /gene="orf19.1935"
FT /Ca19Contig="Ca19-10137|complement(17346..17792)"
FT /synonym="IPF9572.1, Contig4-2985_0002, orf6.831"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS 294667..296523
FT /gene="orf19.1936"
FT /Ca19Contig="Ca19-10137|complement(17991..19847)"
FT /synonym="orf19.9491, IPF9571.2, IPF19131.2, Contig4-
FT 2985_0003, orf6.5603, orf6.832, CA3361"
FT /remarks="Essential protein; functional homolog of S.
FT cerevisiae Snf1p regulator of sugar metabolism;
FT constitutively expressed; Thr208 phosphorylation may have
FT regulatory role; up-regulation associated with azole
FT resistance; has polyhistidine tract"
FT CDS 293764..294402
FT /gene="orf19.1938"
FT /Ca19Contig="Ca19-10137|complement(20112..20750)"
FT /synonym="orf19.9493, IPF9568.1, IPF9569.2, IPF9568,
FT Contig4-2985_0006, orf6.5601, CA3360"
FT /remarks="Decreased transcription is observed in an azole-
FT resistant strain that overexpresses CDR1 and CDR2;
FT increased transcription is observed upon benomyl
FT treatment"
FT CDS complement(291477..292571)
FT /gene="orf19.1939"
FT /Ca19Contig="Ca19-10137|21943..23037"
FT /synonym="orf19.9494, IPF25374.1, IPF9566.2, Contig4-
FT 2985_0012, orf6.5600, CA3359"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(290443..291183)
FT /gene="orf19.1940"
FT /Ca19Contig="Ca19-10137|23331..24071"
FT /synonym="orf19.9495, IPF25378.1, IPF19984.1, Contig4-
FT 2985_0013, orf6.5599, CA3358"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(288720..290129)
FT /gene="orf19.1941"
FT /Ca19Contig="Ca19-10137|24160..25794"
FT /synonym="orf19.9496, IPF25366.1, IPF9562.2, Contig4-
FT 2985_0015, orf6.5598, CA3357"
FT /remarks="Kinetochore component; amount of Nuf2p and Mtw1p
FT protein detected at each centromere is consistent with a
FT single kinetochore microtubule attachment site"
FT CDS 286755..288638
FT /gene="orf19.1942"
FT /Ca19Contig="Ca19-10137|complement(25876..27759)"
FT /synonym="orf19.9497, orf6.5597, IPF9560.2, IPF29247.1,
FT Contig4-2985_0017, CA3356"
FT /remarks="Protein described as a multidrug resistance
FT factor; transcriptionally regulated by iron; expression
FT greater in low iron"
FT CDS 283868..286240
FT /gene="orf19.1943"
FT /Ca19Contig="Ca19-10137|complement(28274..30646)"
FT /synonym="orf19.9498, IPF11277.2, IPF29244.1, Contig4-
FT 2985_0019, Contig4-2985_0020, orf6.5596, CA3355"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 280836..283307
FT /gene="orf19.1944"
FT /Ca19Contig="Ca19-10137|complement(31207..33678)"
FT /synonym="orf19.9499, IPF11281.2, IPF29241.1, Contig4-
FT 2985_0021, Contig4-2985_0023, orf6.5595, CA3354"
FT /remarks="Putative G-protein-coupled receptor of plasma
FT membrane; required for wild-type hyphal growth; acts in
FT cAMP-PKA pathway; reports differ on role in cAMP-mediated
FT glucose signaling; Gpr1p C terminus binds Gpa2p; regulates
FT HWP1 and ECE1"
FT CDS 277008..278423
FT /gene="orf19.1945"
FT /Ca19Contig="Ca19-10137|complement(36091..37506)"
FT /synonym="orf19.9500, IPF11286.2, IPF18866.2, Contig4-
FT 2985_0028, orf6.1971, orf6.5594, CA3353"
FT /remarks="Inositolphosphorylceramide (IPC) synthase,
FT catalyzes the key step in the synthesis of sphingolipids;
FT potential target for antifungal drugs; mutations confer
FT resistance to aureobasidin A"
FT CDS complement(274481..275380)
FT /gene="orf19.1946"
FT /Ca19Contig="Ca19-10137|39134..40033"
FT /synonym="orf19.9501, IPF16195.1, IPF16194.2, Contig4-
FT 1970_0003, orf6.1972, orf6.5593, CA3352"
FT /remarks="Similar to an aldose 1-epimerase-related
FT protein; antigenic during murine systemic infection"
FT CDS 273059..274360
FT /gene="orf19.1948"
FT /Ca19Contig="Ca19-10137|complement(40154..41455)"
FT /synonym="orf19.9504, IPF25376.1, IPF12135.2, Contig4-
FT 2375_0006, orf6.1974, orf6.5591, CA0818"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 270302..272383
FT /gene="orf19.1949"
FT /Ca19Contig="Ca19-10137|complement(42131..44212)"
FT /synonym="orf19.9505, IPF19611.2, IPF19610.1, Contig4-
FT 2375_0001, Contig4-2375_0005, orf6.1975, orf6.919, CA0819"
FT /remarks="Protein described as a dynamin-family GTPase-
FT related protein; induced upon adherence to polystyrene;
FT regulated by Gcn2p and Gcn4p"
FT CDS 269484..269954
FT /gene="orf19.1950"
FT /Ca19Contig="Ca19-10137|complement(44560..45030)"
FT /synonym="orf19.9506, IPF12138.1, IPF18864.1, Contig4-
FT 2077_0005, Contig4-2375_0009, orf6.1976, orf6.918, CA0820"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 268278..269390
FT /gene="orf19.1953"
FT /Ca19Contig="Ca19-10137|complement(45934..46236)"
FT /synonym="orf19.9508, IPF12141, IPF12141.1, IPF18863.1,
FT IPF16834.2, Contig4-2077_0004, orf6.1978, orf6.916,
FT orf6.1979, CA0222, orf19.1952"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; not
FT essential for viability; merged with orf19.1952 in
FT Assembly 21"
FT CDS 266976..268136
FT /gene="orf19.1954"
FT /Ca19Contig="Ca19-10137|complement(46378..47562)"
FT /synonym="orf19.9509, IPF16835.2, IPF12142.3, Contig4-
FT 2077_0003, orf6.1980, orf6.915, CA0221"
FT /remarks="Transcription is regulated by Nrg1p, Mig1p, and
FT Tup1p"
FT CDS join(266079..266705,266780..266809)
FT /gene="orf19.1955"
FT /Ca19Contig="Ca19-10137|complement(47746..48435)"
FT /synonym="orf19.9510, IPF16837.1, IPF14758.2, Contig4-
FT 2077_0002, Contig4-2143_0001, orf6.4084, orf6.914, CA2257"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(262806..265067)
FT /gene="orf19.1956"
FT /Ca19Contig="Ca19-10137|49447..51708"
FT /synonym="orf19.9511, IPF19331.2, IPF14757.2, Contig4-
FT 2143_0002, orf6.342, orf6.4083, CA2256"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 261888..262682
FT /gene="orf19.1957"
FT /Ca19Contig="Ca19-10137|complement(51832..52626)"
FT /synonym="orf19.9512, orf6.4082, IPF14754.1, IPF13303.1,
FT Contig4-2143_0003, orf6.343, CA2255"
FT /remarks="Cytochrome c heme lyase, mitochondrial; gene
FT also encodes antigenic cell-wall protein; mRNA more
FT abundant in filaments than yeast-form; induced on
FT polystyrene adherence, interaction with macrophage; N-
FT glycosylation, 2 heme-binding motifs"
FT CDS 254747..255256
FT /gene="orf19.1958"
FT /Ca19Contig="Ca19-10137|complement(59258..59767)"
FT /synonym="orf19.9513, IPF25382.1, IPF15487.2, Contig4-
FT 2473_0001, orf6.4081, CA2254"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS 253350..254321
FT /gene="orf19.1959"
FT /Ca19Contig="Ca19-10137|complement(60193..61164)"
FT /synonym="orf19.9514, IPF25377.1, IPF15485.2, Contig4-
FT 2473_0003, orf6.4080, CA2253"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(244214..245611)
FT /gene="orf19.1960"
FT /Ca19Contig="Ca19-10137|68903..70300"
FT /synonym="orf19.9515, IPF10874.1, IPF11287.3, Contig4-
FT 2487_0005, orf6.2316, orf6.5045, CA2950"
FT /remarks="G1 cyclin; depletion causes abolished budding
FT and hyphal growth defects; likely to be essential;
FT farnesol regulated, upregulated in biofilm; functional in
FT S. cerevisiae; similar to S. cerevisiae Cln3p, which is a
FT G1-specific cyclin"
FT CDS complement(234864..236456)
FT /gene="orf19.1961"
FT /Ca19Contig="Ca19-10137|78058..79650"
FT /synonym="orf19.9516, IPF14506.1, IPF11296.1, Contig4-
FT 2193_0003, orf6.2315, orf6.5044, CA2949"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(229549..231072)
FT /gene="orf19.1963"
FT /Ca19Contig="Ca19-10137|83442..84965"
FT /synonym="orf19.9519, IPF25364.1, IPF6301.2, Contig4-
FT 2813_0004, orf6.5041, CA2948"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(225963..227465)
FT /gene="orf19.1964"
FT /Ca19Contig="Ca19-10137|87049..88551"
FT /synonym="orf19.9520, IPF25368.1, IPF6298.2, IPF6298,
FT Contig4-2813_0008, orf6.5040, CA2947"
FT /remarks="Putative protein of unknown function;
FT downregulated upon fluphenazine treatment; upregulated
FT upon benomyl treatment and in an RHE model; regulated by
FT Nrg1p, Tup1p"
FT CDS complement(224799..225614)
FT /gene="orf19.1966"
FT /Ca19Contig="Ca19-10137|88900..89715"
FT /synonym="orf19.9522, IPF25379.1, IPF6296.2, Contig4-
FT 2813_0010, orf6.5038, CA2946"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS join(complement(224466..224544),
FT complement(223938..224401))
FT /gene="orf19.1967"
FT /Ca19Contig="Ca19-10137|90100..90576"
FT /synonym="orf19.9523, IPF25383.1, IPF6295.1, Contig4-
FT 2813_0011, orf6.5037, CA2945"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 223546..223869
FT /gene="orf19.1968"
FT /Ca19Contig="Ca19-10137|complement(90645..91055)"
FT /synonym="orf19.9524, IPF25386.1, IPF6294.1, Contig4-
FT 2813_0012, orf6.5036, CA2944"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS complement(222671..222946)
FT /gene="orf19.1968.1"
FT /Ca19Contig="Ca19-10137|91568..91843"
FT /synonym="IPF25390.1, IPF6293.1, Contig4-2813_0014,
FT CA2943"
FT /remarks="ORF Predicted by Annotation Working Group"
FT CDS 221848..222663
FT /gene="orf19.1969"
FT /Ca19Contig="Ca19-10137|complement(91851..92666)"
FT /synonym="orf19.9525, IPF6292.2, IPF6291.1, Contig4-
FT 2813_0016, orf6.5035, CA2942"
FT /remarks="Putative mannoprotein of cell wall with role in
FT response to stress; increased mRNA abundance observed in
FT cyr1 homozygous mutant (hyphal or yeast-form cells) and in
FT ras1 homozygous mutant (yeast-form cells)"
FT CDS complement(220488..221192)
FT /gene="orf19.1970"
FT /Ca19Contig="Ca19-10137|93322..94026"
FT /synonym="orf19.9526, IPF18882.2, IPF6289.1, Contig4-
FT 2813_0019, orf6.5034, CA2941"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 218221..219705
FT /gene="orf19.1971"
FT /Ca19Contig="Ca19-10137|complement(94809..96293)"
FT /synonym="orf19.9527, IPF25369.1, IPF6286.2, Contig4-
FT 2794_0015, orf6.1864, CA0751"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(215867..217288)
FT /gene="orf19.1972"
FT /Ca19Contig="Ca19-10137|97226..98647"
FT /synonym="orf19.9528, IPF25370.1, IPF6284.1, Contig4-
FT 2794_0013, orf6.1863, CA0750"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(214546..215592)
FT /gene="orf19.1973"
FT /Ca19Contig="Ca19-10137|98922..99968"
FT /synonym="orf19.9529, IPF25373.1, IPF6283.2, Contig4-
FT 2794_0012, orf6.1862, CA0749"
FT /remarks="Component of CCAAT-binding transcription factor;
FT roles in filamentous growth, low-iron (chelation)
FT induction of FRP1 transcription; regulates genes with
FT roles in respiratory growth; functional homolog of S.
FT cerevisiae Hap5p"
FT CDS complement(213101..213880)
FT /gene="orf19.1974"
FT /Ca19Contig="Ca19-10137|100634..101413"
FT /synonym="orf19.9530, IPF8684.2, IPF6281.2, Contig4-
FT 2794_0009, orf6.1410, orf6.1861, CA0748"
FT /remarks="Transcription is regulated upon yeast-hyphal
FT switch; shows colony morphology-related gene regulation by
FT Ssn6p"
FT CDS 212577..213023
FT /gene="orf19.1975"
FT /Ca19Contig="Ca19-10137|complement(101491..101937)"
FT /synonym="orf19.9531, IPF8685.2, IPF29250.1, Contig4-
FT 2794_0008, orf6.1409, CA0468"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(211610..211966)
FT /gene="orf19.1976"
FT /Ca19Contig="Ca19-10137|102548..102904"
FT /synonym="orf19.9532, IPF25391.1, IPF8686.2, Contig4-
FT 2794_0006, orf6.1408, CA0467"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(210210..211286)
FT /gene="orf19.1977"
FT /Ca19Contig="Ca19-10137|103228..104304"
FT /synonym="orf19.9533, IPF25375.1, IPF8687.1, Contig4-
FT 2794_0005, orf6.1407, CA0466"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(206349..207953)
FT /gene="orf19.1978"
FT /Ca19Contig="Ca19-10137|106561..108165"
FT /synonym="orf19.9534, IPF18978.2, IPF8692.2, orf6.2482,
FT CA1138"
FT /remarks="Putative glycerophosphoinositol permease; fungal-
FT specific (no human or murine homolog); transcription is
FT repressed in response to alpha pheromone in SpiderM
FT medium"
FT CDS complement(202603..204210)
FT /gene="orf19.1979"
FT /Ca19Contig="Ca19-10137|110304..111911"
FT /synonym="orf19.9535, IPF25363.1, IPF8694.2, Contig4-
FT 2554_0002, orf6.2481, CA1137"
FT /remarks="Putative glycerophosphoinositol permease; fungal-
FT specific (no human or murine homolog); alkaline
FT downregulated; transcription is specific to white cell
FT type; caspofungin repressed; macrophage/pseudohyphal-
FT repressed"
FT CDS complement(199552..201150)
FT /gene="orf19.1980"
FT /Ca19Contig="Ca19-10137|113364..114962"
FT /synonym="orf19.9536, IPF25367.1, IPF8698.2, Contig4-
FT 2554_0005, orf6.2480, CA1136"
FT /remarks="Putative glycerophosphoinositol permease; fungal-
FT specific (no human or murine homolog)"
FT CDS 198650..199138
FT /gene="orf19.1981"
FT /Ca19Contig="Ca19-10137|complement(115376..115864)"
FT /synonym="orf19.9537, IPF25384.1, IPF8699.2, Contig4-
FT 2554_0006, orf6.2479, CA1135"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(777343..778356)
FT /gene="orf19.2637"
FT /Ca19Contig="Ca19-10155|863..1876"
FT /synonym="orf19.10160, IPF24693.1, IPF6961.1, Contig4-
FT 2912_0024, orf6.1458, CA0490"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 772041..772868
FT /gene="orf19.2638"
FT /Ca19Contig="Ca19-10155|complement(6351..7178)"
FT /synonym="orf19.10161, IPF6967.2, IPF18967.2, Contig4-
FT 2912_0019, orf6.1459, orf6.3825, CA2073"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(768150..768671)
FT /gene="orf19.2639"
FT /Ca19Contig="Ca19-10155|10548..11069"
FT /synonym="orf19.10162, IPF24697.1, IPF6970.1, Contig4-
FT 2912_0012, orf6.3824, CA2072"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS join(complement(767776..767784),complement(767467..767689),
FT complement(767257..767396))
FT /gene="orf19.2639.1"
FT /Ca19Contig="Ca19-10155|join(11435..11443,11530..11752,1182
FT 3..11962)"
FT /synonym="IPF24685.1, IPF6971.2, Contig4-2912_0010,
FT CA2071"
FT /remarks="ORF Predicted by Annotation Working Group"
FT CDS complement(766283..766939)
FT /gene="orf19.2640"
FT /Ca19Contig="Ca19-10155|12280..12936"
FT /synonym="orf19.10163, IPF24695.1, IPF6973.2, Contig4-
FT 2912_0008, orf6.3823, CA2069"
FT /remarks="Uracil phosphoribosyltransferase; enzyme of
FT pyrimidine salvage; predicted tetrameric enzyme; mutations
FT are associated with resistance to flucytosine (5-FC) in
FT clinical isolates; macrophage-induced protein; flucytosine
FT induced"
FT CDS 764935..766179
FT /gene="orf19.2641"
FT /Ca19Contig="Ca19-10155|complement(13040..14284)"
FT /synonym="orf19.10164, IPF24691.1, IPF6975.2, Contig4-
FT 2912_0007, orf6.3822, CA2068"
FT /remarks="Protein described as centractin; induced upon
FT adherence to polystyrene"
FT CDS complement(764191..764706)
FT /gene="orf19.2642"
FT /Ca19Contig="Ca19-10155|14513..15028"
FT /synonym="orf19.10165, IPF24696.1, IPF6976.1, Contig4-
FT 2912_0006, orf6.3821, CA2067"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 763528..764001
FT /gene="orf19.2643"
FT /Ca19Contig="Ca19-10155|complement(15218..15691)"
FT /synonym="orf19.10166, IPF24698.1, IPF6977.1, Contig4-
FT 2912_0005, orf6.3820, CA2066"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 762003..763127
FT /gene="orf19.2644"
FT /Ca19Contig="Ca19-10155|complement(16092..17216)"
FT /synonym="orf19.10167, IPF24692.1, IPF6978.2, Contig4-
FT 2912_0002, orf6.3819, CA2065"
FT /remarks="Protein described as ubiquinol-cytochrome-c
FT reductase; antigenic in human; transcriptionally induced
FT by interaction with macrophage; repressed by nitric oxide;
FT in detergent-resistant membrane fraction (possible lipid
FT raft component)"
FT CDS 760524..760844
FT /gene="orf19.2645"
FT /Ca19Contig="Ca19-10155|complement(18375..18695)"
FT /synonym="orf19.10168, IPF24704.1, IPF29040.1, orf6.3818"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(756050..759778)
FT /gene="orf19.2646"
FT /Ca19Contig="Ca19-10155|19441..23169"
FT /synonym="orf19.10169, orf6.3817, IPF13024.2, IPF29039.1,
FT Contig4-2669_0005, orf6.3357, CA2064"
FT /remarks="Predicted zinc-finger protein of unknown
FT function, not essential for viability"
FT CDS complement(754184..755770)
FT /gene="orf19.2647"
FT /Ca19Contig="Ca19-10155|23449..25035"
FT /synonym="orf19.10170, IPF18551.2, IPF13021.1, Contig4-
FT 2669_0003, orf6.3356, orf6.3816, orf6.1256, CA1726"
FT /remarks="Putative transcription factor with zinc cluster
FT DNA-binding motif; caspofungin induced"
FT CDS complement(748891..750012)
FT /gene="orf19.2649"
FT /Ca19Contig="Ca19-10155|29207..30328"
FT /synonym="orf19.10172, IPF16634.2, IPF29037.1, Contig4-
FT 2161_0007, orf6.1258, orf6.3354, CA0384"
FT /remarks="Cyclin homolog; expression induced upon
FT filamentous growth; transcription is induced in response
FT to alpha pheromone in SpiderM medium"
FT CDS complement(745173..747470)
FT /gene="orf19.2650"
FT /Ca19Contig="Ca19-10155|31749..34046"
FT /synonym="orf19.10173, IPF19008.2, IPF15985.1, Contig4-
FT 2161_0002, Contig4-2161_0003, orf6.3353, CA1725"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(744333..744620)
FT /gene="orf19.2650.1"
FT /Ca19Contig="Ca19-10155|34599..34886"
FT /synonym="IPF24703.1, IPF18618.1, CA1724"
FT /remarks="ORF Predicted by Annotation Working Group"
FT CDS 742856..744115
FT /gene="orf19.2651"
FT /Ca19Contig="Ca19-10155|complement(35104..36363)"
FT /synonym="orf19.10174, IPF24690.1, IPF16860.2, Contig4-
FT 2002_0004, orf6.3352, CA1723"
FT /remarks="Putative translation elongation factor; genes
FT encoding ribosomal subunits, translation factors, and tRNA
FT synthetases are downregulated upon phagocytosis by murine
FT macrophage"
FT CDS 741779..742438
FT /gene="orf19.2652"
FT /Ca19Contig="Ca19-10155|complement(36781..37440)"
FT /synonym="orf19.10175, IPF24694.1, IPF16861.2, Contig4-
FT 2002_0002, orf6.3351, CA1722"
FT /remarks="Putative translation elongation factor; genes
FT encoding ribosomal subunits, translation factors, and tRNA
FT synthetases are downregulated upon phagocytosis by murine
FT macrophage"
FT CDS complement(736919..740200)
FT /gene="orf19.2653"
FT /Ca19Contig="Ca19-10155|39019..42300"
FT /synonym="orf19.10176, IPF14652, IPF24706.1, IPF14652.2,
FT Contig4-2474_0003, orf6.3350, CA1721"
FT /remarks="Protein not essential for viability"
FT CDS 734722..736380
FT /gene="orf19.2654"
FT /Ca19Contig="Ca19-10155|complement(42839..44497)"
FT /synonym="orf19.10177, IPF10588.2, IPF29036.1, Contig4-
FT 2474_0006, orf6.3349, orf6.721, CA0161"
FT /remarks="Protein induced during the mating process"
FT CDS 731837..732958
FT /gene="orf19.2655"
FT /Ca19Contig="Ca19-10155|complement(46261..47382)"
FT /synonym="orf19.10178, IPF19171.2, IPF10586.2, Contig4-
FT 2474_0008, orf6.1509, orf6.722, CA0526"
FT /remarks="Protein similar to S. cerevisiae Bub3p, which is
FT a kinetochore checkpoint component; induced under
FT hydroxyurea treatment"
FT CDS complement(726085..728208)
FT /gene="orf19.2657"
FT /Ca19Contig="Ca19-10155|51011..53134"
FT /synonym="orf19.10180, IPF24686.1, IPF16538.3"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 467497..467790
FT /gene="orf19.3159.4"
FT /Ca19Contig="Ca19-10170|complement(4465..4758)"
FT /synonym="IPF3152.1, IPF28869.1, Contig4-2734_0009"
FT /remarks="ORF Predicted by Annotation Working Group"
FT CDS complement(466373..466879)
FT /gene="orf19.3160"
FT /Ca19Contig="Ca19-10170|5376..5882"
FT /synonym="orf19.10669, orf19.13883, orf6.1668, IPF3160.2,
FT CA0627"
FT /remarks="Heat-shock protein; induced upon
FT osmotic/oxidative/cadmium stress, fluphenazine treatment,
FT low iron, CDR1 and CDR2 overexpression, or ssn6 or ssk1
FT homozygous null mutation; repressed by Hog1p, flucytosine,
FT elevated CO2"
FT CDS complement(464440..465402)
FT /gene="orf19.3161"
FT /Ca19Contig="Ca19-10170|6829..7815"
FT /synonym="orf19.10670, IPF17400.3, IPF3161.2, Contig4-
FT 2939_0012, orf6.1667, orf6.1772, CA0626"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 463418..464404
FT /gene="orf19.3163"
FT /Ca19Contig="Ca19-10170|complement(7851..8837)"
FT /synonym="orf19.10672, IPF19637.2, IPF28863.1, Contig4-
FT 2939_0011, orf6.1665, orf6.2675, CA0625"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 458193..463202
FT /gene="orf19.3166"
FT /Ca19Contig="Ca19-10170|complement(9053..14062)"
FT /synonym="orf19.10675, IPF24132.1, IPF3170.2, Contig4-
FT 2939_0010, orf6.2672, CA1260"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 456472..457857
FT /gene="orf19.3167"
FT /Ca19Contig="Ca19-10170|complement(14398..15783)"
FT /synonym="orf19.10676, IPF3174.2, IPF19016.2, Contig4-
FT 2939_0006, orf6.1237, orf6.2671, CA1259"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 455238..456230
FT /gene="orf19.3168"
FT /Ca19Contig="Ca19-10170|complement(16025..17017)"
FT /synonym="orf19.10677, IPF18724.1, IPF3176.2, Contig4-
FT 2939_0004, orf6.1236, orf6.2670, CA1258"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT transcription is regulated by Mig1p; regulated by Gcn2p
FT and Gcn4p"
FT CDS complement(453845..454903)
FT /gene="orf19.3169"
FT /Ca19Contig="Ca19-10170|17352..18410"
FT /synonym="orf19.10678, IPF18725.1, IPF3177.2, Contig4-
FT 2939_0002, orf6.1235, orf6.2669, CA1257"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(451382..453568)
FT /gene="orf19.3170"
FT /Ca19Contig="Ca19-10170|18687..20873"
FT /synonym="orf19.10680, IPF18726.2, IPF3178.2, Contig4-
FT 2939_0001, orf6.1165, orf6.1234, orf6.2668, CA0378"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(446995..448569)
FT /gene="orf19.3171"
FT /Ca19Contig="Ca19-10170|23686..25260"
FT /synonym="orf19.10681, IPF12009.2, IPF28861.1, Contig4-
FT 1566_0005, orf6.1164, orf6.1238, CA0345"
FT /remarks="Soluble protein in hyphae; similar to S.
FT cerevisiae Ach1p, which is acetyl-coA hydrolase required
FT for acetate utilization; nonessential; antigenic in human;
FT induced on polystyrene adherence; ketoconazole-induced; no
FT human or murine homolog"
FT CDS 446231..446632
FT /gene="orf19.3172"
FT /Ca19Contig="Ca19-10170|complement(25623..26024)"
FT /synonym="orf19.10682, IPF12010.2, IPF28867.1, Contig4-
FT 1566_0001, Contig4-1691_0001, orf6.1163, orf6.1239"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(444864..445544)
FT /gene="orf19.3173"
FT /Ca19Contig="Ca19-10170|26711..27391"
FT /synonym="orf19.10683, IPF19030.2, IPF12012.2, Contig4-
FT 1691_0006, orf6.1240, CA0379"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(440832..443366)
FT /gene="orf19.3174"
FT /Ca19Contig="Ca19-10170|28889..31423"
FT /synonym="orf19.10684, IPF19624.1, IPF19625.1, Contig4-
FT 2507_0005, orf6.1241, orf6.1482, CA0509"
FT /remarks="GDP-GTP exchange factor for Cdc42p;
FT phosphorylated; required for maintenance of hyphal growth;
FT misexpression blocks hyphal growth and causes avirulence
FT in a mouse model of systemic infection; antigenic during
FT human oral infection"
FT CDS complement(438165..440048)
FT /gene="orf19.3175"
FT /Ca19Contig="Ca19-10170|32207..34090"
FT /synonym="orf19.10685, IPF16916.2, IPF16824.3, Contig4-
FT 2507_0007, Contig4-2507_0008, orf6.1483, orf6.4472,
FT YOR256W, CA0510"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT alkaline downregulated; repressed by nitric oxide"
FT CDS complement(435999..437588)
FT /gene="orf19.3176"
FT /Ca19Contig="Ca19-10170|34667..36256"
FT /synonym="orf19.10686, IPF16822.2, IPF12782.2, Contig4-
FT 2507_0010, orf6.1484, orf6.4473, CA2530"
FT /remarks="Protein involved in the pH response pathway;
FT required for activation of the transcription factor
FT Rim101p and for alkaline pH-induced hyphal growth; may
FT function as a sensor of alkaline pH"
FT CDS 434212..435981
FT /gene="orf19.3177"
FT /Ca19Contig="Ca19-10170|complement(36274..38043)"
FT /synonym="orf19.10687, IPF24120.1, IPF12784.2, Contig4-
FT 2248_0008, orf6.4474, CA2531"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 432444..433985
FT /gene="orf19.3178"
FT /Ca19Contig="Ca19-10170|complement(38270..39811)"
FT /synonym="orf19.10688, IPF24121.1, IPF20105.1, Contig4-
FT 2248_0005, orf6.4475, CA2532"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(430872..432245)
FT /gene="orf19.3180"
FT /Ca19Contig="Ca19-10170|40010..41383"
FT /synonym="orf19.10690, IPF24125.1, IPF12790.2, Contig4-
FT 1727_0007, Contig4-2248_0003, orf6.4477, CA2533"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(428884..429048)
FT /gene="orf19.3181.1"
FT /Ca19Contig="Ca19-10170|43207..43371"
FT /synonym="IPF24116.1, IPF20106.1, CA2535"
FT /remarks="ORF Predicted by Annotation Working Group"
FT CDS 429623..430150
FT /gene="orf19.3182"
FT /Ca19Contig="Ca19-10170|complement(42105..42632)"
FT /synonym="orf19.10692, orf6.4479, IPF24129.1, IPF12793.2,
FT Contig4-1727_0004, CA2534"
FT /remarks="Transcriptionally regulated by iron; expression
FT greater in high iron; transcription reduced upon yeast-
FT hyphal switch; similar to proteins that bind nucleic acid"
FT CDS 428137..428811
FT /gene="orf19.3183"
FT /Ca19Contig="Ca19-10170|complement(43444..44118)"
FT /synonym="orf19.10693, IPF24127.1, IPF20107.1, Contig4-
FT 1727_0001, Contig4-2288_0006, orf6.4480, CA2536"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS complement(427225..427872)
FT /gene="orf19.3184"
FT /Ca19Contig="Ca19-10170|44383..45030"
FT /synonym="orf19.10694, IPF24126.1, IPF20108.1, Contig4-
FT 2288_0005, orf6.4481, CA2537"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 424769..427117
FT /gene="orf19.3185"
FT /Ca19Contig="Ca19-10170|complement(45138..47486)"
FT /synonym="orf19.10695, IPF24113.1, IPF15324.2, Contig4-
FT 2288_0004, orf6.4482, CA2538"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 424411..424746
FT /gene="orf19.3186"
FT /Ca19Contig="Ca19-10170|complement(47509..47844)"
FT /synonym="IPF28870.1, orf6.4483"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(420956..423724)
FT /gene="orf19.3187"
FT /Ca19Contig="Ca19-10170|48531..51299"
FT /synonym="orf19.10697, IPF17473.2, IPF9188.2, Contig4-
FT 2456_0001, orf6.4484, orf6.852, orf6.853, CA2539"
FT /remarks="Putative transcription factor; has Zn(2)-Cys(6)
FT binuclear cluster; predicted to bind DNA; regulated by
FT Gcn2p and Gcn4p; gene is located in zinc cluster region of
FT Chromosome 5, near the MTL locus"
FT CDS complement(416430..419375)
FT /gene="orf19.3188"
FT /Ca19Contig="Ca19-10170|join(52880..53065,53069..55825)"
FT /synonym="orf19.10700, orf19.10699, IPF19124.2, IPF9191.2,
FT Contig4-2456_0006, orf6.1024, orf6.4485, orf6.854,
FT orf6.4486, orf6.855, TAC1-1, TAC1-2, CA2541, orf19.3189"
FT /remarks="Transcriptional activator of drug-responsive
FT genes including CDR1 and CDR2; has Zn(2)-Cys(6) binuclear
FT cluster; binds DRE element; gene in zinc cluster region
FT near MTL locus; resequencing indicates that TAC1 spans
FT orf19.3188 and orf19.3189"
FT CDS complement(411974..415006)
FT /gene="orf19.3190"
FT /Ca19Contig="Ca19-10170|57249..60281"
FT /synonym="orf19.10701, IPF9196.1, IPF16067.2, Contig4-
FT 1956_0001, Contig4-1956_0002, orf6.4487, CA2542"
FT /remarks="Protein with Zn(2)-Cys(6) binuclear cluster;
FT gene in zinc cluster region of Chr. 5; transcriptionally
FT activated by Mnl1p in weak acid; similar to S. cerevisiae
FT Hal9p, which is a putative transcription factor involved
FT in salt tolerance"
FT CDS 409958..411727
FT /gene="orf19.3192"
FT /Ca19Contig="Ca19-10170|complement(join(61720..62298,60528.
FT .61724))"
FT /synonym="orf19.10702, orf6.1022, IPF9198.3, IPF19105.2,
FT Contig4-1933_0004, orf6.4488, orf6.905, CA0265, CA6273,
FT orf19.3191"
FT /remarks="Protein that interacts with Cdc37p and Crk1p in
FT the two-hybrid system; potential ortholog of S. cerevisiae
FT Sti1p; may be involved in Cdc37p chaperone activity;
FT biofilm induced; soluble protein in hyphae"
FT CDS 407977..409176
FT /gene="orf19.3193"
FT /Ca19Contig="Ca19-10170|complement(63080..64279)"
FT /synonym="orf19.10704, orf6.906, IPF19842.1, IPF19852.1,
FT Contig4-2798_0003, orf6.715, orf6.716, CA0219"
FT /remarks="Transcriptional regulator of the bZip family;
FT partially functionally complements the fluconazole
FT sensitivity of an S. cerevisiae pdr1 pdr3 double mutant;
FT probable ortholog of S. cerevisiae Yap3p"
FT CDS complement(402835..404634)
FT /gene="orf19.3195"
FT /Ca19Contig="Ca19-10170|67622..69421"
FT /synonym="orf19.10706, IPF11171.3, IPF28855.1, Contig4-
FT 2559_0006, orf6.1878, orf6.4405, orf6.713, orf6.908,
FT CA0160"
FT /remarks="Alkaline upregulated; flucytosine induced;
FT regulated by Plc1p, Gcn2p and Gcn4p; fungal-specific (no
FT human or murine homolog)"
FT CDS complement(402485..402787)
FT /gene="orf19.3196"
FT /Ca19Contig="Ca19-10170|69469..69771"
FT /synonym="IPF24136.1, IPF28871.1, orf6.1879"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 400510..402177
FT /gene="orf19.3197"
FT /Ca19Contig="Ca19-10170|complement(70079..71746)"
FT /synonym="IPF9850.1, IPF19882.1, Contig4-2559_0008,
FT Contig4-2559_0009, orf6.1880, PAPa, CA0758"
FT /remarks="Poly(A) polymerase, likely involved in mRNA
FT polyadenylation; gene is located within the MTLa mating-
FT type-like locus"
FT CDS complement(398803..400104)
FT /gene="orf19.3198"
FT /Ca19Contig="Ca19-10170|72152..73453"
FT /synonym="IPF9854.2, IPF11167.1, Contig4-1502_0001,
FT Contig4-1611_0001, Contig4-2559_0010, orf6.1881, CA0759"
FT /remarks="Similar to oxysterol binding protein; gene is
FT located within the MTLa mating-type-like locus; Plc1p-
FT regulated"
FT CDS complement(395368..398238)
FT /gene="orf19.3199"
FT /Ca19Contig="Ca19-10170|74018..76888"
FT /synonym="IPF9853.1, IPF11166.2, Contig4-1611_0004,
FT Contig4-2559_0011, Contig4-2559_0013, orf6.1882, CA6207"
FT /remarks="Putative phosphatidylinositol kinase; gene is
FT located within the MTLa mating-type-like locus"
FT CDS join(complement(394984..395253),
FT complement(394593..394928))
FT /gene="orf19.3200"
FT /Ca19Contig="Ca19-10170|join(77003..77272,77328..77663)"
FT /synonym="A2, IPF11164.1, orf6.1883"
FT /remarks="Master regulator (activator) of a-type mating;
FT has HMG domain, which is predicted to bind DNA; gene has
FT intron; not related to S. cerevisiae MATa2; a/alpha mating
FT type may increase virulence, provides competitive
FT advantage"
FT CDS join(complement(394297..394488),complement(393851..394222),
FT complement(393526..393594))
FT /gene="orf19.3201"
FT /Ca19Contig="Ca19-10170|join(77768..77959,78034..78438)"
FT /synonym="A1, IPF11162.1, IPF11161.2, Contig4-2559_0015,
FT orf6.1884, CA0760"
FT /remarks="A1p and Alpha2p act together to repress white-
FT opaque switching and mating (an opaque-specific process);
FT homeodomain protein; gene of the MTLa (Mating Type Like)
FT locus; a/alpha mating type may increase virulence,
FT competitive advantage"
FT CDS 390739..393300
FT /gene="orf19.3202"
FT /Ca19Contig="Ca19-10170|complement(78956..81517)"
FT /synonym="orf19.10714, IPF9846, IPF9846.2, IPF28851.1,
FT Contig4-2661_0004, Contig4-2661_0006, orf6.4397, CA2484"
FT /remarks="Protein not essential for viability"
FT CDS complement(387781..390336)
FT /gene="orf19.3203"
FT /Ca19Contig="Ca19-10170|81920..84475"
FT /synonym="orf19.10715, IPF24110.1, IPF19758.1, Contig4-
FT 2661_0007, Contig4-2661_0008, orf6.4396, CA2483"
FT /remarks="Putative F-box protein involved in endocytic
FT membrane traffic and/or recycling; fungal-specific (no
FT human or murine homolog)"
FT CDS complement(385311..387527)
FT /gene="orf19.3204"
FT /Ca19Contig="Ca19-10170|84729..86945"
FT /synonym="orf19.10716, IPF24114.1, IPF9841.1, Contig4-
FT 2661_0010, orf6.4395, CA2482"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 384458..385090
FT /gene="orf19.3205"
FT /Ca19Contig="Ca19-10170|complement(87166..87798)"
FT /synonym="orf19.10717, IPF24128.1, IPF9838.2, Contig4-
FT 2661_0011, orf6.4394, CA2481"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(382508..384157)
FT /gene="orf19.3206"
FT /Ca19Contig="Ca19-10170|88099..89748"
FT /synonym="orf19.10718, IPF9837.2, IPF28858.1, Contig4-
FT 2661_0012, orf6.158, orf6.4393, CA2480"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(377678..379759)
FT /gene="orf19.3207"
FT /Ca19Contig="Ca19-10170|92497..94578"
FT /synonym="orf19.10719, IPF24117.1, IPF15597.2, Contig4-
FT 2538_0006, orf6.4392, CA2479"
FT /remarks="G1 cyclin; required for hyphal growth
FT maintenance (not initiation); cell-cycle regulated
FT transcription (G1/S); Cdc28p-Ccn1p initiates Cdc11p S394
FT phosphorylation on hyphal induction; expression in S.
FT cerevisiae inhibits pheromone response"
FT CDS 375493..377133
FT /gene="orf19.3208"
FT /Ca19Contig="Ca19-10170|complement(95123..96763)"
FT /synonym="orf19.10720, IPF24124.1, IPF14177.2, Contig4-
FT 2538_0004, Contig4-2538_0005, orf6.1025, orf6.4391,
FT CA2478"
FT /remarks="Putative allantoate permease; fungal-specific
FT (no human or murine homolog); not essential for viability;
FT similar to S. cerevisiae Dal5p"
FT CDS complement(889368..889682)
FT /gene="orf19.3209"
FT /Ca19Contig="Ca19-10171|787..1101"
FT /synonym="IPF24103.1, IPF28845.1, Contig4-2463_0016,
FT orf6.1699"
FT /remarks="Protein lacking an ortholog in S. cerevisiae;
FT transposon mutation affects filamentous growth"
FT CDS complement(882434..883072)
FT /gene="orf19.3210"
FT /Ca19Contig="Ca19-10171|7397..8035"
FT /synonym="orf19.10722, IPF24100.1, IPF12399.2, Contig4-
FT 2463_0004, orf6.1700, CA0648"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; Plc1p-
FT regulated; possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS join(881301..881332,881404..882415)
FT /gene="orf19.3211"
FT /Ca19Contig="Ca19-10171|complement(8054..9139)"
FT /synonym="orf19.10723, IPF24099.1, IPF12401.3, Contig4-
FT 2463_0002, orf6.1701, orf6.849, CA0649"
FT /remarks="Transcription is induced upon filamentous
FT growth"
FT CDS 879385..881061
FT /gene="orf19.3212"
FT /Ca19Contig="Ca19-10171|complement(9408..11084)"
FT /synonym="orf19.10724, IPF12820.2, IPF19250.2, Contig4-
FT 2443_0001, orf6.496, orf6.848, CA0203"
FT /remarks="Putative component of the high affinity calcium
FT uptake system; role in thigmotropism; decreased
FT transcription is observed upon fluphenazine treatment or
FT in an azole-resistant strain with CDR1 and CDR2
FT overexpression"
FT CDS 876524..879001
FT /gene="orf19.3213"
FT /Ca19Contig="Ca19-10171|complement(11468..13945)"
FT /synonym="orf19.10725, IPF24092.1, IPF12819.3, Contig4-
FT 2443_0003, orf6.3195, orf6.495, orf6.847, CA0094"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 873713..875197
FT /gene="orf19.3214"
FT /Ca19Contig="Ca19-10171|complement(15486..16757)"
FT /synonym="orf19.10726, IPF24098.1, IPF12814.2, Contig4-
FT 2443_0006, orf6.3196, CA1612"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS 872183..872572
FT /gene="orf19.3215"
FT /Ca19Contig="Ca19-10171|complement(17898..18287)"
FT /synonym="orf19.10727, IPF24104.1, IPF19735.1, Contig4-
FT 1643_0001, Contig4-1643_0002, orf6.3197, CA1613"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT transcription is repressed in response to alpha pheromone
FT in SpiderM medium"
FT CDS 868715..871219
FT /gene="orf19.3216"
FT /Ca19Contig="Ca19-10171|complement(19251..21755)"
FT /synonym="orf19.10728, orf6.243, IPF18645.1, IPF12592.3,
FT Contig4-2220_0003, orf6.3198, CA1614"
FT /remarks="Similar to Rab GTPase activators"
FT CDS complement(863725..865191)
FT /gene="orf19.3218"
FT /Ca19Contig="Ca19-10171|25279..26745"
FT /synonym="orf19.10729, IPF14540, IPF24097.1, IPF14540.2,
FT Contig4-2205_0008, orf6.3199, CA1615"
FT /remarks="Putative multidrug resistance protein;
FT upregulated by Efg1p"
FT CDS complement(859577..861382)
FT /gene="orf19.3219"
FT /Ca19Contig="Ca19-10171|29088..30893"
FT /synonym="orf19.10730, IPF24094.1, IPF14538.2, Contig4-
FT 2205_0004, Contig4-2205_0005, orf6.3200, CA1616"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(858541..859146)
FT /gene="orf19.3220"
FT /Ca19Contig="Ca19-10171|31324..31929"
FT /synonym="orf19.10731, IPF24101.1, IPF14536.2, Contig4-
FT 2889_0006, orf6.3201, CA1617"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 916885..918405
FT /gene="orf19.3893"
FT /Ca19Contig="Ca19-10194|2..976"
FT /synonym="orf19.11374, orf6.2346, IPF23274.1, IPF15862.2,
FT CA1053"
FT /remarks="Cell wall protein; transcription is decreased in
FT mutant lacking ACE2; downregulated in core caspofungin
FT response; transcriptionally regulated by iron; expression
FT greater in high iron"
FT CDS complement(918498..919520)
FT /gene="orf19.3894"
FT /Ca19Contig="Ca19-10194|complement(1069..2091)"
FT /synonym="orf19.11375, IPF23270.1, IPF15861.1, Contig4-
FT 2459_0001, orf6.2345, CA1052"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(919805..921556)
FT /gene="orf19.3895"
FT /Ca19Contig="Ca19-10194|complement(2376..4127)"
FT /synonym="orf19.11376, orf6.2344, IPF19719.2, IPF15860.2,
FT Contig4-2459_0002, CA1051"
FT /remarks="Chitinase; putative N-terminal catalytic domain,
FT GPI anchor, O-mannosylated region, signal peptide; 3 N-
FT glycosylation motifs; downregulated in core caspofungin
FT response; induced in yeast-form cells; Cyr1p-, Efg1p-, pH-
FT regulated"
FT CDS 924687..925949
FT /gene="orf19.3897"
FT /Ca19Contig="Ca19-10194|7258..8520"
FT /synonym="orf19.11378, IPF23260.1, IPF19897.1, Contig4-
FT 2263_0011, orf6.2342, CA1050"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT decreased transcription is observed upon fluphenazine
FT treatment or in an azole-resistant strain that
FT overexpresses CDR1 and CDR2; transcription is repressed in
FT response to alpha pheromone in SpiderM medium"
FT CDS complement(926613..927296)
FT /gene="orf19.3898"
FT /Ca19Contig="Ca19-10194|complement(9184..9867)"
FT /synonym="orf19.11379, IPF23297.1, IPF15393.2, Contig4-
FT 2263_0009, orf6.2341, CA1049"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 927539..927925
FT /gene="orf19.3899"
FT /Ca19Contig="Ca19-10194|10110..10496"
FT /synonym="orf19.11380, IPF18393.2, IPF15394.1, Contig4-
FT 2263_0007, orf6.2340, CA1048"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 928268..929875
FT /gene="orf19.3900"
FT /Ca19Contig="Ca19-10194|10839..12446"
FT /synonym="orf19.11381, IPF20126.1, IPF20071.1, Contig4-
FT 2263_0006, orf6.2339, orf6.5148, CA3027"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 930439..931956
FT /gene="orf19.3901"
FT /Ca19Contig="Ca19-10194|13010..14527"
FT /synonym="orf19.11382, IPF11499.2, IPF28558.1, Contig4-
FT 2263_0001, Contig4-2263_0003, orf6.5147, CA3026"
FT /remarks="Putative benzene desulfurase; induced by nitric
FT oxide in yhb1 mutant"
FT CDS 933782..934528
FT /gene="orf19.3902"
FT /Ca19Contig="Ca19-10194|16353..17099"
FT /synonym="orf19.11383, IPF23291.1, IPF11503.1, Contig4-
FT 2296_0005, orf6.5146, CA3025"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT decreased transcription is observed upon fluphenazine
FT treatment or in an azole-resistant strain that
FT overexpresses CDR1 and CDR2"
FT CDS 936301..936888
FT /gene="orf19.3903"
FT /Ca19Contig="Ca19-10194|18872..19459"
FT /synonym="orf19.11384, IPF23309.1, IPF11506.2, Contig4-
FT 2296_0001, orf6.5145, CA3024"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(937242..938012)
FT /gene="orf19.3904"
FT /Ca19Contig="Ca19-10194|complement(19813..20583)"
FT /synonym="orf19.11385, IPF23281.1, IPF11508.2, orf6.5144,
FT CA3023"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 939322..939963
FT /gene="orf19.3905"
FT /Ca19Contig="Ca19-10194|21893..22534"
FT /synonym="orf19.11386, IPF23298.1, IPF17642.2, Contig4-
FT 1931_0001, orf6.5143, CA3022"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 940701..941291
FT /gene="orf19.3906"
FT /Ca19Contig="Ca19-10194|23272..23862"
FT /synonym="orf19.11387, IPF23302.1, IPF17640.2, orf6.5142,
FT CA3021"
FT /remarks="Protein not essential for viability"
FT CDS complement(942355..942666)
FT /gene="orf19.3907"
FT /Ca19Contig="Ca19-10194|complement(24926..25237)"
FT /synonym="orf19.11388, IPF23361.1, IPF28591.1, orf6.5141"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 943043..943657
FT /gene="orf19.3908"
FT /Ca19Contig="Ca19-10194|25614..26228"
FT /synonym="orf19.11389, IPF23305.1, IPF15492.2, Contig4-
FT 2027_0003, orf6.5140, CA3020"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 944280..945521
FT /gene="orf19.3910"
FT /Ca19Contig="Ca19-10194|26851..28092"
FT /synonym="orf19.11391, IPF23262.1, IPF15494.2, Contig4-
FT 2817_0009, orf6.5138, CA3019"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(946010..947362)
FT /gene="orf19.3911"
FT /Ca19Contig="Ca19-10194|complement(28581..29933)"
FT /synonym="orf19.11392, IPF23243.1, IPF10018.2, Contig4-
FT 2730_0002, orf6.5137, CA3018"
FT /remarks="Protein described as S-adenosyl-L-homocysteine
FT hydrolase; predicted enzyme of sulfur amino acid
FT metabolism; antigenic in human; biofilm-, alkaline-,
FT fluconazole-induced expression; Gcn4p-regulated; amino
FT acid starvation (3-AT) repressed"
FT CDS complement(947849..949897)
FT /gene="orf19.3912"
FT /Ca19Contig="Ca19-10194|complement(30420..32468)"
FT /synonym="orf19.11393, IPF10021.2, IPF28549.1, Contig4-
FT 2730_0003, orf6.5136, CA3017"
FT /remarks="GATA transcription factor involved in regulation
FT of filamentous growth induced by nitrogen starvation;
FT regulates transcription of Mep2p ammonium permease;
FT regulated by Gcn2p and Gcn4p"
FT CDS complement(952095..953387)
FT /gene="orf19.3914"
FT /Ca19Contig="Ca19-10194|complement(34666..35958)"
FT /synonym="orf19.11396, IPF10027.2, IPF28563.1, Contig4-
FT 2194_0001, Contig4-2730_0010, orf6.5133, CA3016"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(954174..955478)
FT /gene="orf19.3915"
FT /Ca19Contig="Ca19-10194|complement(36745..38202)"
FT /synonym="orf19.11397, IPF10029.2, IPF18505.2, Contig4-
FT 2730_0012, orf6.4061, orf6.5132, CA2239"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; Hog1p-
FT induced"
FT CDS 956373..957956
FT /gene="orf19.3916"
FT /Ca19Contig="Ca19-10194|join(38944..39981,39983..40528)"
FT /synonym="orf19.11398, orf19.11399, IPF23300.1,
FT IPF12695.2, Contig4-2398_0001, Contig4-2730_0015,
FT orf6.4060, orf6.4059, CA2238, CA2237, orf19.3917"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(958171..960282)
FT /gene="orf19.3919"
FT /Ca19Contig="Ca19-10194|complement(40743..42854)"
FT /synonym="orf19.11401, IPF23216.1, IPF12694.2, Contig4-
FT 2398_0003, orf6.4057, CA2236"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 960781..961050
FT /gene="orf19.3919.1"
FT /remarks="ORF added to Assembly 21 based on comparative
FT genome analysis"
FT CDS 961504..962403
FT /gene="orf19.3920"
FT /Ca19Contig="Ca19-10194|44076..44975"
FT /synonym="orf19.11402, IPF19135.2, IPF12689.1, Contig4-
FT 2398_0006, Contig4-2398_0008, orf6.4056, CA2235"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(962440..963291)
FT /gene="orf19.3921"
FT /Ca19Contig="Ca19-10194|complement(45012..45863)"
FT /synonym="orf19.11403, IPF12688.2, IPF28566.1, Contig4-
FT 2398_0009, orf6.4055, orf6.824, CA0195"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(963452..964315)
FT /gene="orf19.3922"
FT /Ca19Contig="Ca19-10194|complement(46024..46887)"
FT /synonym="orf19.11404, IPF16228.2, IPF28565.1, Contig4-
FT 2398_0010, orf6.4054, orf6.823, CA0194"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(965202..965828)
FT /gene="orf19.3923"
FT /Ca19Contig="Ca19-10194|complement(47774..48400)"
FT /synonym="orf19.11405, IPF16226.2, IPF10922.2, Contig4-
FT 1606_0001, Contig4-1924_0002, orf6.4053, orf6.822, CA2234"
FT /remarks="Putative GPI-anchored protein of unknown
FT function"
FT CDS complement(966936..968075)
FT /gene="orf19.3924"
FT /Ca19Contig="Ca19-10194|complement(49508..50743)"
FT /synonym="orf19.11406, IPF10925.3, IPF10924.2, Contig4-
FT 2817_0014, orf6.4052, CA2233"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(970227..970682)
FT /gene="orf19.3925"
FT /Ca19Contig="Ca19-10194|complement(52799..53254)"
FT /synonym="orf19.11407, IPF23304.1, IPF10929.1, Contig4-
FT 2817_0011, orf6.4051, CA2232"
FT /remarks="Putative protein of unknown function,
FT transcription is activated in the presence of elevated
FT CO2; predicted ORF in Assemblies 19, 20 and 21"
FT CDS 971643..972842
FT /gene="orf19.3926"
FT /Ca19Contig="Ca19-10194|54215..55414"
FT /synonym="orf19.11408, IPF23264.1, IPF10934.2, Contig4-
FT 2817_0009, orf6.4050, CA2231"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(973109..974251)
FT /gene="orf19.3928"
FT /Ca19Contig="Ca19-10194|complement(55681..56823)"
FT /synonym="orf19.11410, IPF23263.1, IPF10936.2, Contig4-
FT 2817_0008, orf6.4048, CA2230"
FT /remarks="Putative transcription factor with zinc finger
FT DNA-binding motif"
FT CDS 974703..975740
FT /gene="orf19.3929"
FT /Ca19Contig="Ca19-10194|57275..58312"
FT /synonym="orf19.11411, IPF14603.2, IPF28564.1, Contig4-
FT 2817_0007, orf6.1917, orf6.4047, CA0785"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS join(complement(976734..976772),
FT complement(975762..976664))
FT /gene="orf19.3930"
FT /Ca19Contig="Ca19-10194|complement(58334..58891)"
FT /synonym="orf19.11412, IPF23280.1, IPF14602.1, Contig4-
FT 2817_0006, orf6.1916, CA0784"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT described as similar to ubiquitin carboxyl-terminal
FT hydrolases"
FT CDS complement(977075..977986)
FT /gene="orf19.3931"
FT /Ca19Contig="Ca19-10194|complement(59647..60558)"
FT /synonym="orf19.11413, IPF23279.1, IPF14601.2, Contig4-
FT 2817_0005, orf6.1915, CA0783"
FT /remarks="Alkaline upregulated"
FT CDS complement(979125..979427)
FT /gene="orf19.3931.1"
FT /remarks="Pseudogene; added to Assembly 21 based on
FT comparative genome analysis"
FT CDS complement(979462..979644)
FT /gene="orf19.3931.2"
FT /remarks="ORF added to Assembly 21 based on comparative
FT genome analysis"
FT CDS complement(979946..980773)
FT /gene="orf19.3932"
FT /Ca19Contig="Ca19-10194|complement(62518..63345)"
FT /synonym="orf19.11414, IPF16253.2, IPF28567.1, Contig4-
FT 2817_0002, orf6.1914, CA0782"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT induced in core caspofungin response; increased expression
FT observed in an ssr1 homozygous null mutant; induced by
FT nitric oxide in yhb1 mutant"
FT CDS complement(981211..981480)
FT /gene="orf19.3932.1"
FT /remarks="ORF added to Assembly 21 based on comparative
FT genome analysis"
FT CDS complement(981892..982845)
FT /gene="orf19.3934"
FT /Ca19Contig="Ca19-10194|complement(64464..65417)"
FT /synonym="orf19.11416, IPF16256.2, IPF10187.1, Contig4-
FT 2929_0002, orf6.1912, orf6.2297"
FT /remarks="Transcription is regulated by Nrg1p, Mig1p, and
FT Tup1p; shows colony morphology-related gene regulation by
FT Ssn6p; alkaline upregulated"
FT CDS 983153..983455
FT /gene="orf19.3935"
FT /Ca19Contig="Ca19-10194|65725..66027"
FT /synonym="orf19.11417, IPF23364.1, IPF28593.1, orf6.2298"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 984182..987670
FT /gene="orf19.3936"
FT /Ca19Contig="Ca19-10194|66754..70242"
FT /synonym="orf19.11418, IPF23353.1, IPF10184.2, Contig4-
FT 2929_0005, Contig4-2929_0006, orf6.2299, CA1025"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT induced upon biofilm formation"
FT CDS 987898..989079
FT /gene="orf19.3937"
FT /Ca19Contig="Ca19-10194|join(70470..70996,71095..71653)"
FT /synonym="orf19.11419, IPF10824.3, IPF19645.1, Contig4-
FT 2929_0008, orf6.2300, orf6.3224, CA1026"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 989309..990097
FT /gene="orf19.3938"
FT /Ca19Contig="Ca19-10194|71883..72671"
FT /synonym="orf19.11420, IPF10823.1, IPF10181.1, Contig4-
FT 2929_0009, orf6.2301, orf6.3225, CA1632"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 991305..992213
FT /gene="orf19.3939"
FT /Ca19Contig="Ca19-10194|73648..74787"
FT /synonym="orf19.11421, IPF10820.1, IPF10179.1, Contig4-
FT 2929_0012, orf6.2302, orf6.3226, CA1634"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(990173..991075)
FT /gene="orf19.3940"
FT /Ca19Contig="Ca19-10194|complement(72747..73649)"
FT /synonym="orf19.11422, IPF10822.1, IPF10180.1, Contig4-
FT 2929_0011, orf6.2303, orf6.3227, CA1633"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS complement(992430..992531)
FT /gene="orf19.3940.1"
FT /Ca19Contig="Ca19-10194|complement(75004..75105)"
FT /synonym="orf19.11422.1"
FT /remarks="Metallothionein, involved in copper resistance;
FT transcription is induced by copper"
FT CDS complement(993756..995477)
FT /gene="orf19.3941"
FT /Ca19Contig="Ca19-10194|complement(76330..78051)"
FT /synonym="orf19.11423, IPF23233.1, IPF10815.2, Contig4-
FT 2929_0016, orf6.3228, CA1635"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT flucytosine induced"
FT CDS complement(996174..996764)
FT /gene="orf19.3942"
FT /Ca19Contig="Ca19-10194|complement(78748..79338)"
FT /synonym="orf19.11424, IPF23299.1, IPF20086.1, Contig4-
FT 2929_0018, orf6.3229, CA1636"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS join(complement(997795..997796),
FT complement(997147..997423))
FT /gene="orf19.3942.1"
FT /Ca19Contig="Ca19-10194|complement(join(80368..80370,79721.
FT .79996))"
FT /synonym="IPF23373.1, IPF20087.1, Contig4-2929_0019,
FT CA1637"
FT /remarks="Downregulated in the presence of human whole
FT blood or polymorphonuclear (PMN) cells; shows colony
FT morphology-related gene regulation by Ssn6p"
FT CDS complement(998281..1000623)
FT /gene="orf19.3944"
FT /Ca19Contig="Ca19-10194|complement(80855..83197)"
FT /synonym="orf19.11426, IPF23206.1, IPF14608.2, Contig4-
FT 1767_0001, Contig4-1767_0003, Contig4-2929_0020,
FT orf6.3231, CA1638"
FT /remarks="Protein involved in the negative control of
FT pseudohyphal growth; ortholog of S. cerevisiae
FT Grr1p, which is an F-box protein component of the SCF
FT ubiquitin-ligase complex required for cell cycle
FT progression"
FT CDS 1002133..1003563
FT /gene="orf19.3945"
FT /Ca19Contig="Ca19-10194|84707..86137"
FT /synonym="orf19.11427, IPF23250.1, IPF13799.3, Contig4-
FT 1800_0002, orf6.2412, CA1089"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1003703..1004587)
FT /gene="orf19.3946"
FT /Ca19Contig="Ca19-10194|complement(86277..87272)"
FT /synonym="orf19.11428, IPF23271.1, IPF13798.1, Contig4-
FT 1800_0004, orf6.2413, CA1090"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1004931..1005269
FT /gene="orf19.3947"
FT /Ca19Contig="Ca19-10194|87505..87843"
FT /synonym="orf19.11429, IPF18764.2, IPF13796.2, Contig4-
FT 1800_0006, orf6.2414, CA1091"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1005395..1009339)
FT /gene="orf19.3949"
FT /Ca19Contig="Ca19-10194|complement(87969..91913)"
FT /synonym="orf19.11431, IPF23338.1, IPF13795.2, orf6.2416,
FT CA1092"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1010265..1011998)
FT /gene="orf19.3950"
FT /Ca19Contig="Ca19-10194|complement(92839..94572)"
FT /synonym="orf19.11432, IPF23232.1, IPF19722.1, orf6.2417,
FT CA1093"
FT /remarks="Mitochondrial methionyl-tRNA synthetase (MetRS);
FT functionally complements methionine auxotrophy of an E.
FT coli MetRS mutant; transcription is regulated by Nrg1p"
FT CDS complement(1012190..1012945)
FT /gene="orf19.3951"
FT /Ca19Contig="Ca19-10194|complement(94764..95519)"
FT /synonym="orf19.11433, IPF18796.2, IPF16770.2, Contig4-
FT 1802_0003, orf6.2274, orf6.2418, CA1094"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1013452..1015059
FT /gene="orf19.3952"
FT /Ca19Contig="Ca19-10194|96026..97633"
FT /synonym="orf19.11434, IPF19895.1, IPF19901.2, Contig4-
FT 2292_0006, orf6.2275, orf6.2419, orf6.928, CA1011"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1015820..1019032
FT /gene="orf19.3954"
FT /Ca19Contig="Ca19-10194|98394..101606"
FT /synonym="orf19.11436, IPF14208.2, IPF19402.2, Contig4-
FT 2292_0003, orf6.181, orf6.2277, CA1012"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1019126..1019362)
FT /gene="orf19.3954.1"
FT /remarks="ORF added to Assembly 21 based on comparative
FT genome analysis"
FT CDS complement(1020202..1022448)
FT /gene="orf19.3955"
FT /Ca19Contig="Ca19-10194|complement(102776..105022)"
FT /synonym="orf19.11437, IPF15550.2, IPF28546.1, Contig4-
FT 1832_0002, orf6.182, orf6.2278, CA1014"
FT /remarks="Cytoplasmic methionyl-tRNA synthetase (MetRS);
FT has zinc-binding motif; genes encoding ribosomal subunits,
FT translation factors, and tRNA synthetases are
FT downregulated upon phagocytosis by murine macrophage"
FT CDS 1022725..1024077
FT /gene="orf19.3956"
FT /Ca19Contig="Ca19-10194|105299..106651"
FT /synonym="orf19.11438, IPF15547.2, IPF28562.1, Contig4-
FT 1832_0003, orf6.1120, orf6.2279, CA1015"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1024403..1025233)
FT /gene="orf19.3957"
FT /Ca19Contig="Ca19-10194|complement(106977..107807)"
FT /synonym="orf19.11439, IPF23282.1, IPF5793.2, orf6.1119,
FT CA0318"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1025693..1029517)
FT /gene="orf19.3959"
FT /Ca19Contig="Ca19-10194|complement(108267..112091)"
FT /synonym="orf19.11441, IPF18942.2, IPF5791.2, Contig4-
FT 3081_0004, orf6.1117, orf6.1554, CA0317"
FT /remarks="Protein with role in resistance to host
FT antimicrobial peptides; virulence role in murine
FT infection; functional homolog of S. cerevisiae Ssd1p,
FT which suppresses various mutant phenotypes; constitutively
FT expressed and not cell-cycle regulated"
FT CDS complement(1031080..1032504)
FT /gene="orf19.3960"
FT /Ca19Contig="Ca19-10194|complement(113654..115078)"
FT /synonym="orf19.11442, IPF23248.1, IPF5785.1, Contig4-
FT 3081_0006, orf6.1553, CA0555"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1032724..1034421)
FT /gene="orf19.3962"
FT /Ca19Contig="Ca19-10194|complement(115298..116995)"
FT /synonym="orf19.11444, IPF5784.3, IPF28555.1, Contig4-
FT 3081_0007, Contig4-3081_0009, orf6.1551, orf6.3509,
FT CA0554"
FT /remarks="Functional homolog of S. cerevisiae Has1p, which
FT is a nucleolar protein of the DEAD-box ATP-dependent RNA
FT helicase family that is involved in biogenesis of the
FT ribosome, particularly the small (40S) subunit;
FT caspofungin-downregulated"
FT CDS 1035482..1036357
FT /gene="orf19.3963"
FT /Ca19Contig="Ca19-10194|118056..118931"
FT /synonym="orf19.11445, IPF23275.1, IPF5777.1, Contig4-
FT 3081_0010, orf6.3508, CA1838"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1036689..1038089
FT /gene="orf19.3964"
FT /Ca19Contig="Ca19-10194|119263..120663"
FT /synonym="orf19.11446, IPF23249.1, IPF5776.1, Contig4-
FT 3081_0012, orf6.3507, CA1837"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1038084..1038734)
FT /gene="orf19.3965"
FT /Ca19Contig="Ca19-10194|complement(120658..121398)"
FT /synonym="orf19.11447, IPF18603.2, IPF5773.2, Contig4-
FT 3081_0013, orf6.3506, CA1836"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT possibly spurious ORF (Annotation Working Group
FT prediction)"
FT CDS 1039173..1040687
FT /gene="orf19.3966"
FT /Ca19Contig="Ca19-10194|121747..123261"
FT /synonym="orf19.11448, IPF23240.1, IPF5772.2, Contig4-
FT 3081_0014, orf6.3505, CA1835"
FT /remarks="Putative cell wall protein, member of the CRH
FT family; transcription is regulated by Nrg1p and Tup1p;
FT alkaline upregulated by Rim101p; repressed during cell
FT wall regeneration"
FT CDS 1041235..1044198
FT /gene="orf19.3967"
FT /Ca19Contig="Ca19-10194|123809..126772"
FT /synonym="orf19.11449, IPF23197.1, IPF5769.1, Contig4-
FT 3081_0016, orf6.3504, CA1834"
FT /remarks="Alpha subunit of phosphofructokinase (PFK),
FT which is Pfk1p, Pfk2p heteromultimer; PFK is activated by
FT fructose 2,6-bisphosphate or AMP, inhibited by ATP;
FT activity reduced on hyphal induction; phagocytosis-
FT downregulated; fluconazole-induced"
FT CDS 1051721..1052032
FT /gene="orf19.3968"
FT /Ca19Contig="Ca19-10194|134295..134606"
FT /synonym="orf19.11451, IPF23347.1, IPF28582.1, orf6.2745"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1053870..1056014
FT /gene="orf19.3969"
FT /Ca19Contig="Ca19-10194|136444..138588"
FT /synonym="orf19.11452, IPF8627.2, IPF28547.1, Contig4-
FT 3081_0036, orf6.2746, CA1309"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1058136..1058879)
FT /gene="orf19.3970"
FT /Ca19Contig="Ca19-10194|complement(140710..141453)"
FT /synonym="orf19.11453, IPF23293.1, IPF13616.2, Contig4-
FT 3081_0042, orf6.5646, CA3395"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1059086..1059844
FT /gene="orf19.3971"
FT /Ca19Contig="Ca19-10194|141660..142418"
FT /synonym="orf19.11454, IPF23290.1, IPF13617.2, Contig4-
FT 3081_0043, orf6.5647, CA3396"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS join(complement(1060505..1060529),
FT complement(1060009..1060406))
FT /gene="orf19.3972"
FT /Ca19Contig="Ca19-10194|complement(142583..142987)"
FT /synonym="orf19.11455, IPF23326.1, IPF13618.1, Contig4-
FT 3081_0045, orf6.5648, CA3397"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1061136..1061921
FT /gene="orf19.3973"
FT /Ca19Contig="Ca19-10194|143710..144495"
FT /synonym="orf19.11456, IPF23285.1, IPF13621.2, Contig4-
FT 3081_0047, orf6.5649, CA3398"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1062095..1063882)
FT /gene="orf19.3974"
FT /Ca19Contig="Ca19-10194|complement(144669..146456)"
FT /synonym="orf19.11457, IPF23228.1, IPF13622.2, Contig4-
FT 3081_0050, orf6.5650, CA3399"
FT /remarks="Alkaline upregulated"
FT CDS complement(1064270..1065391)
FT /gene="orf19.3976"
FT /Ca19Contig="Ca19-10194|complement(146844..147965)"
FT /synonym="orf19.11459, IPF23268.1, IPF13623.2, Contig4-
FT 3081_0052, orf6.5652, CA3400"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1065640..1066749)
FT /gene="orf19.3977"
FT /Ca19Contig="Ca19-10194|complement(148214..149323)"
FT /synonym="orf19.11460, IPF23267.1, IPF8652.2, orf6.5653,
FT CA3401"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1066976..1067689
FT /gene="orf19.3978"
FT /Ca19Contig="Ca19-10194|149550..150263"
FT /synonym="orf19.11461, IPF23296.1, IPF8651.2, Contig4-
FT 1327_0001, orf6.5654, CA3402"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1067930..1073719)
FT /gene="orf19.3980"
FT /Ca19Contig="Ca19-10194|complement(150504..156293)"
FT /synonym="orf19.11463, IPF23311.1, IPF8650.2, Contig4-
FT 1327_0003, orf6.5656, CA3403"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1074239..1076005)
FT /gene="orf19.3981"
FT /Ca19Contig="Ca19-10194|complement(156813..158579)"
FT /synonym="orf19.11464, IPF23226.1, IPF8647.2, orf6.5657,
FT CA3404"
FT /remarks="Putative protein of unknown function,
FT transcription is upregulated in clinical isolates from
FT HIV+ patients with oral candidiasis; alkaline upregulated"
FT CDS 1078944..1080692
FT /gene="orf19.3982"
FT /Ca19Contig="Ca19-10194|161518..163266"
FT /synonym="orf19.11465, IPF23227.1, IPF8644.2, orf6.5658,
FT CA3405"
FT /remarks="Maltase; induced during growth on sucrose;
FT transcription is induced in response to alpha pheromone in
FT SpiderM medium"
FT CDS complement(1080849..1083059)
FT /gene="orf19.3983"
FT /Ca19Contig="Ca19-10194|complement(163423..165633)"
FT /synonym="orf19.11466, IPF23209.1, IPF9711.2, Contig4-
FT 2652_0007, orf6.5659, CA3406"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1088560..1091088
FT /gene="orf19.3984"
FT /Ca19Contig="Ca19-10194|171134..173662"
FT /synonym="orf19.11467, IPF19142.1, IPF18339.2, orf6.5660,
FT orf6.7397, orf6.794, CA0184"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT induced in core caspofungin response; increased expression
FT observed in an ssr1 homozygous null mutant; induced by
FT nitric oxide in yhb1 mutant"
FT CDS complement(1091736..1094318)
FT /gene="orf19.3986"
FT /Ca19Contig="Ca19-10194|complement(174310..176892)"
FT /synonym="orf19.11469, IPF19144.2, IPF9661.2, Contig4-
FT 2740_0001, orf6.7399, orf6.793, CA4758"
FT /remarks="Putative transcription factor with zinc cluster
FT DNA-binding motif; has similarity to S. cerevisiae Ppr1p,
FT which is a transcription factor involved in the regulation
FT of uracil biosynthesis genes"
FT CDS 1095702..1097429
FT /gene="orf19.3988"
FT /Ca19Contig="Ca19-10194|178276..180003"
FT /synonym="orf19.11471, IPF23230.1, IPF9655.1, Contig4-
FT 2740_0007, orf6.7401, CA4759"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT transcriptionally activated by Mnl1p under weak acid
FT stress"
FT CDS 1097705..1098196
FT /gene="orf19.3990"
FT /Ca19Contig="Ca19-10194|180279..180770"
FT /synonym="orf19.11473, IPF23301.1, IPF9652.2, Contig4-
FT 2740_0008, orf6.7403, CA4760"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1098265..1100466)
FT /gene="orf19.3991"
FT /Ca19Contig="Ca19-10194|complement(180839..183088)"
FT /synonym="orf19.11474, IPF23210.1, IPF9651.2, Contig4-
FT 2740_0011, Contig4-2740_0012, orf6.7404, CA4761"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1100896..1101210
FT /gene="orf19.3992"
FT /Ca19Contig="Ca19-10194|183470..183784"
FT /synonym="orf19.11475, orf6.7405"
FT /remarks="Predicted ORF from Assembly 19; removed from
FT Assembly 20; subsequently reinstated in Assembly 21 based
FT on comparative genome analysis"
FT CDS complement(1101287..1102477)
FT /gene="orf19.3994"
FT /Ca19Contig="Ca19-10194|complement(183861..185051)"
FT /synonym="orf19.11477, IPF23265.1, IPF9647.2, Contig4-
FT 2740_0015, Contig4-2740_0016, Contig4-2740_0017,
FT orf6.7407, CA4762"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1102520..1104673)
FT /gene="orf19.3995"
FT /Ca19Contig="Ca19-10194|complement(185094..187247)"
FT /synonym="orf19.11478, IPF23213.1, IPF9645.2, Contig4-
FT 2740_0018, orf6.7408, CA4763"
FT /remarks="Probable protease involved in the pH response
FT pathway, likely to mediate activation of the transcription
FT factor Rim101p via C-terminal cleavage; required for
FT alkaline pH-induced hyphal growth and for normal levels of
FT chlamydospore formation"
FT CDS 1104781..1106229
FT /gene="orf19.3996"
FT /Ca19Contig="Ca19-10194|187355..188803"
FT /synonym="orf19.11479, IPF23255.1, IPF19803.1, Contig4-
FT 2740_0019, orf6.7409, CA4764"
FT /remarks="Putative mannosyltransferase; similar to S.
FT cerevisiae Gpi10p; has HKEXRF motif"
FT CDS 1107682..1108986
FT /gene="orf19.3997"
FT /Ca19Contig="Ca19-10194|190256..191560"
FT /synonym="orf19.11480, ADH, CAD, IPF13058.3, IPF17060.2,
FT Contig4-2534_0002, Contig4-2534_0003, orf6.106, orf6.7410,
FT CA4765"
FT /remarks="Alcohol dehydrogenase; at surface of yeast-form
FT cells but not hyphae; soluble in hyphae; immunogenic in
FT human or mouse; complements S. cerevisiae adh1 adh2 adh3
FT mutation; regulated by growth phase, carbon source;
FT fluconazole-induced"
FT CDS complement(1109131..1109616)
FT /gene="orf19.3998"
FT /Ca19Contig="Ca19-10194|complement(191705..192190)"
FT /synonym="orf19.11481, IPF19441.2, IPF13056.2, Contig4-
FT 2534_0004, orf6.105, orf6.7411, CA4766"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1109886..1112189
FT /gene="orf19.3999"
FT /Ca19Contig="Ca19-10194|192460..194763"
FT /synonym="orf19.11482, IPF23207.1, IPF13054.2, Contig4-
FT 2534_0009, orf6.7412, CA4767"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1119088..1121145
FT /gene="orf19.4000"
FT /Ca19Contig="Ca19-10194|201662..203719"
FT /synonym="orf19.11483, IPF23219.1, IPF9385.1, Contig4-
FT 2616_0006, Contig4-2616_0007, orf6.7413, CA4768"
FT /remarks="Putative homeodomain transcription factor;
FT predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1121602..1122867
FT /gene="orf19.4001"
FT /Ca19Contig="Ca19-10194|204176..205441"
FT /synonym="orf19.11484, IPF23254.1, IPF9384.2, Contig4-
FT 2616_0008, orf6.7414, CA4769"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS join(complement(1124624..1124644),
FT complement(1122956..1124527))
FT /gene="orf19.4002"
FT /Ca19Contig="Ca19-10194|complement(join(207198..207218,2055
FT 30..207101))"
FT /synonym="orf19.11485, IPF23241.1, IPF9382.2, Contig4-
FT 2616_0009, orf6.7415, CA4770"
FT /remarks="Protein similar to S. cerevisiae Dun1p, which is
FT a serine-threonine protein kinase involved in DNA damage
FT cell-cycle checkpoint; induced under Cdc5p depletion"
FT CDS complement(1125216..1127570)
FT /gene="orf19.4003"
FT /Ca19Contig="Ca19-10194|complement(207790..210144)"
FT /synonym="orf19.11486, orf6.7416, IPF23205.1, IPF3336.2,
FT Contig4-2616_0011, CA4771"
FT /remarks="Protein interacting with Sec20p, possibly
FT involved in retrograde transport between the Golgi and the
FT endoplasmic reticulum; similar to S. cerevisiae Tip20p"
FT CDS 1127833..1129422
FT /gene="orf19.4004"
FT /Ca19Contig="Ca19-10194|210407..211996"
FT /synonym="orf19.11487, IPF23237.1, IPF3339.1, Contig4-
FT 3094_0053, orf6.7417, CA4772"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1129477..1130202)
FT /gene="orf19.4005"
FT /Ca19Contig="Ca19-10194|complement(212051..212776)"
FT /synonym="orf19.11488, IPF23294.1, IPF3340.2, Contig4-
FT 3094_0052, orf6.7418, YDR196, CA4773"
FT /remarks="Protein likely to be essential for growth, based
FT on an insertional mutagenesis strategy"
FT CDS 1130323..1131381
FT /gene="orf19.4006"
FT /Ca19Contig="Ca19-10194|212897..213955"
FT /synonym="orf19.11489, IPF23269.1, IPF3341.2, Contig4-
FT 3094_0050, orf6.7419, CA4774"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1131376..1132677)
FT /gene="orf19.4007"
FT /Ca19Contig="Ca19-10194|complement(213950..215251)"
FT /synonym="orf19.11490, IPF23257.1, IPF3342.1, Contig4-
FT 3094_0048, orf6.7420, CA4775"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1132855..1133376)
FT /gene="orf19.4009"
FT /Ca19Contig="Ca19-10194|complement(215429..216034)"
FT /synonym="orf19.11492, IPF23308.1, IPF3344.2, Contig4-
FT 3094_0046, orf6.7422, CA4776"
FT /remarks="Regulatory subunit of calcineurin B (Ca[2+]-
FT calmodulin-regulated S/T protein phosphatase); required
FT for wild-type resistance to fluconazole or to SDS"
FT CDS 1133879..1135975
FT /gene="orf19.4010"
FT /Ca19Contig="Ca19-10194|216453..218549"
FT /synonym="orf19.11493, IPF23217.1, IPF3345.2, Contig4-
FT 3094_0045, orf6.7423, CA4777"
FT /remarks="Protein not essential for viability; similar to
FT S. cerevisiae Pan3p, which is a subunit of an RNAse
FT complex that controls poly(A) tail length"
FT CDS 1137207..1138430
FT /gene="orf19.4011"
FT /Ca19Contig="Ca19-10194|219781..221004"
FT /synonym="orf19.11494, IPF23261.1, IPF3348.1, Contig4-
FT 3094_0043, orf6.7424, CA4778"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1139318..1140232
FT /gene="orf19.4012"
FT /Ca19Contig="Ca19-10194|221892..222806"
FT /synonym="orf19.11495, IPF23278.1, IPF3351.1, Contig4-
FT 3094_0041, orf6.7425, CA4779"
FT /remarks="Protein similar to S. cerevisiae Pcl5p and other
FT cyclins for Pho85p kinase; Gcn4p-induced; suppresses
FT toxicity of C. albicans Gcn4p overproduction in S.
FT cerevisiae via increased Pho85p-dependent phosphorylation
FT and degradation of Gcn4p"
FT CDS complement(1140299..1141603)
FT /gene="orf19.4013"
FT /Ca19Contig="Ca19-10194|complement(222873..224222)"
FT /synonym="orf19.11496, IPF23252.1, IPF3352.2, Contig4-
FT 3094_0040, orf6.7426, CA4780"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1141942..1143390
FT /gene="orf19.4014"
FT /Ca19Contig="Ca19-10194|224516..225964"
FT /synonym="orf19.11497, IPF3355, IPF23246.1, IPF3355.2,
FT Contig4-3094_0038, orf6.7427, CA4781"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT described as similar to S. cerevisiae Cdc1p; induced upon
FT adherence to polystyrene"
FT CDS 1143585..1144874
FT /gene="orf19.4015"
FT /Ca19Contig="Ca19-10194|226159..227448"
FT /synonym="orf19.11498, IPF23259.1, IPF3356.2, Contig4-
FT 3094_0037, orf6.7428, CA4782"
FT /remarks="Alpha subunit of heterotrimeric G protein;
FT positive role in mating pheromone response; more mRNA in
FT opaque than white cells; transcriptionally repressed by
FT MTLa1p-MTLalpha2p complex; regulated by hemoglobin-
FT responsive Hbr1p via MTL genes"
FT CDS complement(1144965..1146284)
FT /gene="orf19.4016"
FT /Ca19Contig="Ca19-10194|complement(227539..228858)"
FT /synonym="orf19.11499, IPF23251.1, IPF3358.2, Contig4-
FT 3094_0036, orf6.7429, CA4783"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT amphotericin B induced; repressed by nitric oxide"
FT CDS complement(1146553..1147497)
FT /gene="orf19.4017"
FT /Ca19Contig="Ca19-10194|complement(229127..230071)"
FT /synonym="orf19.11500, IPF23276.1, IPF3359.2, Contig4-
FT 3094_0034, orf6.7430, CA4784"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1147686..1148441)
FT /gene="orf19.4018"
FT /Ca19Contig="Ca19-10194|complement(230260..231015)"
FT /synonym="orf19.11501, IPF23288.1, IPF3361.2, Contig4-
FT 3094_0032, orf6.7431, CA4785"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1148592..1149212
FT /gene="orf19.4019"
FT /Ca19Contig="Ca19-10194|231166..231786"
FT /synonym="orf19.11502, IPF23286.1, IPF3362.2, Contig4-
FT 3094_0031, orf6.7432, CA4786"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1149257..1150168)
FT /gene="orf19.4021"
FT /Ca19Contig="Ca19-10194|complement(231831..232742)"
FT /synonym="orf19.11504, IPF23277.1, IPF3364.1, Contig4-
FT 3094_0029, orf6.7434, CA4787"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1150309..1150803)
FT /gene="orf19.4022"
FT /Ca19Contig="Ca19-10194|complement(232883..233377)"
FT /synonym="orf19.11505, orf6.7435, IPF23310.1, IPF3365.1,
FT Contig4-3094_0028, CA4788"
FT /remarks="Succinate dehydrogenase, membrane subunit;
FT transcriptionally regulated by iron; expression greater in
FT high iron"
FT CDS complement(1150975..1151322)
FT /gene="orf19.4023"
FT /Ca19Contig="Ca19-10194|complement(233549..233896)"
FT /synonym="orf19.11506, IPF23339.1, IPF3366.1, Contig4-
FT 3094_0027, orf6.7436, CA4789"
FT /remarks="Protein similar to S. cerevisiae Mrp2p, which is
FT a component of the small subunit of the mitochondrial
FT ribosome; transposon mutation affects filamentous growth"
FT CDS 1151737..1152450
FT /gene="orf19.4024"
FT /Ca19Contig="Ca19-10194|234185..235024"
FT /synonym="orf19.11507, IPF23284.1, IPF3367.1, Contig4-
FT 3094_0026, orf6.7437, CA4790"
FT /remarks="Putative riboflavin synthase; fungal-specific
FT (no human or murine homolog)"
FT CDS 1152595..1153185
FT /gene="orf19.4025"
FT /Ca19Contig="Ca19-10194|235169..235759"
FT /synonym="orf19.11508, IPF23307.1, IPF3370.2, Contig4-
FT 3094_0024, orf6.7438, CA4791"
FT /remarks="Upregulated by Rim101p at acid pH; flucytosine
FT induced; amphotericin B repressed"
FT CDS complement(1153238..1154134)
FT /gene="orf19.4026"
FT /Ca19Contig="Ca19-10194|complement(235812..236708)"
FT /synonym="orf19.11509, IPF23273.1, IPF3372.2, Contig4-
FT 3094_0023, orf6.7439, CA4792"
FT /remarks="ATP phosphoribosyl transferase; enzyme of
FT histidine biosynthesis; fungal-specific (no human, murine
FT homolog); upregulated in biofilm; acid
FT upregulated/alkaline downregulated by Rim101p; regulated
FT by Gcn2p, Gcn4p; strain CA9 is a his1 mutant"
FT CDS complement(1154366..1155352)
FT /gene="orf19.4028"
FT /Ca19Contig="Ca19-10194|complement(236940..237926)"
FT /synonym="orf19.11511, IPF23272.1, IPF3375.1, Contig4-
FT 3094_0021, orf6.7441, CA4793"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1155795..1157042
FT /gene="orf19.4029"
FT /Ca19Contig="Ca19-10194|238369..239616"
FT /synonym="orf19.11512, IPF23256.1, IPF3377.1, Contig4-
FT 3094_0019, orf6.7442, CA4794"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1157239..1158513
FT /gene="orf19.4030"
FT /Ca19Contig="Ca19-10194|239729..241087"
FT /synonym="orf19.11513, IPF23253.1, IPF3378.2, Contig4-
FT 3094_0017, orf6.7443, CA4795"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1158544..1161237)
FT /gene="orf19.4031"
FT /Ca19Contig="Ca19-10194|complement(241118..243811)"
FT /synonym="orf19.11514, IPF23202.1, IPF3380.2, Contig4-
FT 3094_0016, orf6.7444, CA4796"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1164565..1165941
FT /gene="orf19.4032"
FT /Ca19Contig="Ca19-10194|join(247139..247723,247725..248516)
FT "
FT /synonym="orf19.11515, orf19.11517, IPF23283.1, IPF8798.1,
FT Contig4-3094_0010, Contig4-3094_0011, orf6.7445,
FT orf6.7447, CA4798, CA4799, orf19.4034"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT macrophage/pseudohyphal-repressed"
FT CDS complement(1161417..1164407)
FT /gene="orf19.4033"
FT /Ca19Contig="Ca19-10194|complement(243991..246981)"
FT /synonym="orf19.11516, IPF23374.1, IPF8801.2, Contig4-
FT 3094_0013, orf6.7446, CA4797"
FT /remarks="Protein described as an RNA-dependent ATPase;
FT induced upon adherence to polystyrene; transcriptionally
FT activated by Mnl1p under weak acid stress"
FT CDS complement(1165960..1167315)
FT /gene="orf19.4035"
FT /Ca19Contig="Ca19-10194|complement(248535..249890)"
FT /synonym="orf19.11518, IPF23247.1, IPF8796.1, Contig4-
FT 3094_0009, orf6.7448, CA4800"
FT /remarks="Cell-surface protein; predicted
FT glycosylphosphatidylinositol (GPI) lipid anchor; similar
FT to S. cerevisiae Gas1p; fungal-specific (no human or
FT murine homolog); transcription is upregulated in RHE model
FT of oral candidiasis"
FT CDS 1168153..1169469
FT /gene="orf19.4036"
FT /Ca19Contig="Ca19-10194|250728..252044"
FT /synonym="orf19.11519, IPF23258.1, IPF8795.1, Contig4-
FT 3094_0006, orf6.7449, CA4801"
FT /remarks="Protein similar to S. cerevisiae Apm1, which is
FT involved in vesicle transport; transposon mutation affects
FT filamentous growth"
FT CDS complement(1169517..1171286)
FT /gene="orf19.4040"
FT /Ca19Contig="Ca19-10194|complement(252092..253861)"
FT /synonym="orf19.11523, IPF7211.3, IPF8790.2, Contig4-
FT 3094_0005, orf6.4407, orf6.7453, CA4802"
FT /remarks="Putative dihydroxyacid dehydratase; fungal-
FT specific (no human or murine homolog); upregulated in
FT biofilm; S. cerevisiae ortholog is Gcn4p regulated;
FT repressed by nitric oxide; macrophage-induced protein"
FT CDS 1172145..1172669
FT /gene="orf19.4041"
FT /Ca19Contig="Ca19-10194|254720..255244"
FT /synonym="orf19.11524, IPF8784.1, IPF7214.1, Contig4-
FT 3094_0004, orf6.4408, orf6.7454, CA4803"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(1172694..1174952)
FT /gene="orf19.4043"
FT /Ca19Contig="Ca19-10194|complement(255269..257527)"
FT /synonym="orf19.11525, IPF7217.2, IPF8783.3, Contig4-
FT 3094_0003, orf6.4409, orf6.7456, CA2489"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT transcription is induced in response to alpha pheromone in
FT SpiderM medium"
FT CDS complement(1175225..1175905)
FT /gene="orf19.4044"
FT /Ca19Contig="Ca19-10194|complement(257800..258480)"
FT /synonym="orf19.11526, IPF23292.1, IPF7220.2, Contig4-
FT 3094_0002, orf6.4410, CA2490"
FT /remarks="Protein similar to S. cerevisiae Mum2p;
FT transcription is induced in response to alpha pheromone in
FT SpiderM medium; transcription is regulated by Tup1p"
FT CDS 1176415..1178253
FT /gene="orf19.4045"
FT /Ca19Contig="Ca19-10194|258990..260828"
FT /synonym="orf19.11527, orf6.4411, IPF23224.1, IPF7224.2,
FT Contig4-2715_0009, CA2492"
FT /remarks="Telomerase subunit; allosteric activator of
FT catalytic activity, but not required for catalytic
FT activity; has TPR domain"
FT CDS complement(1175955..1176416)
FT /gene="orf19.4046"
FT /Ca19Contig="Ca19-10194|complement(258530..258991)"
FT /synonym="orf19.11528, IPF23317.1, IPF7221.2, Contig4-
FT 3094_0001, orf6.4412, CA2491"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 1178347..1179459
FT /gene="orf19.4048"
FT /Ca19Contig="Ca19-10194|260922..262034"
FT /synonym="orf19.11530, IPF23266.1, IPF7227.2, Contig4-
FT 2715_0008, orf6.4414, CA2493"
FT /remarks="Putative delta-4 sphingolipid desaturase"
FT CDS complement(1179456..1180961)
FT /gene="orf19.4051"
FT /Ca19Contig="Ca19-10194|complement(262031..263536)"
FT /synonym="orf19.11533, IPF23244.1, IPF7230.2, Contig4-
FT 2715_0007, orf6.4417, CA2494"
FT /remarks="Putative tRNA-His synthetase; genes encoding
FT ribosomal subunits, translation factors, and tRNA
FT synthetases are downregulated upon phagocytosis by murine
FT macrophage"
FT CDS complement(1182169..1182927)
FT /gene="orf19.4054"
FT /Ca19Contig="Ca19-10194|complement(264744..265502)"
FT /synonym="orf19.11536, IPF23289.1, IPF7233.2, Contig4-
FT 2715_0005, orf6.1799, orf6.4420, CA2495"
FT /remarks="Putative transcriptional activator,
FT downregulated by Efg1p; member of a family of telomere-
FT proximal genes; transcription is upregulated in an RHE
FT model of oral candidiasis"
FT CDS complement(1188806..1189117)
FT /gene="orf19.4055"
FT /Ca19Contig="Ca19-10194|complement(271381..271692)"
FT /synonym="orf19.11537, IPF23360.1, IPF3468.2, Contig4-
FT 2210_0004, orf6.4421, YBR075W, CA2496"
FT /remarks="Protein similar to S. cerevisiae Ybr075wp;
FT transposon mutation affects filamentous growth"
FT CDS complement(315402..317987)
FT /gene="orf19.4131"
FT /Ca19Contig="Ca19-10198|complement(581..3166)"
FT /synonym="orf19.11608, IPF23115.1, IPF14870.2, Contig4-
FT 2911_0018, Contig4-2911_0019, orf6.2616, CA1223"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS join(318368..318410,318479..318687)
FT /gene="orf19.4132"
FT /Ca19Contig="Ca19-10198|3387..3866"
FT /synonym="orf19.11609, IPF23123.1, IPF14871.1, Contig4-
FT 2911_0016, orf6.2615, CA1222"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(319510..320892)
FT /gene="orf19.4133"
FT /Ca19Contig="Ca19-10198|complement(4689..6071)"
FT /synonym="orf19.11610, IPF23119.1, IPF14872.2, Contig4-
FT 2911_0014, orf6.2614, CA1221"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(321043..322260)
FT /gene="orf19.4134"
FT /Ca19Contig="Ca19-10198|complement(6222..7439)"
FT /synonym="orf19.11611, IPF23120.1, IPF14985.2, Contig4-
FT 2911_0013, orf6.2613, CA1220"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS 322744..324240
FT /gene="orf19.4135"
FT /Ca19Contig="Ca19-10198|7923..9419"
FT /synonym="orf19.11612, IPF9814.2, IPF14986.2, Contig4-
FT 2911_0012, orf6.2612, orf6.5243, CA1219"
FT /remarks="Protein described as a carboxypeptidase;
FT upregulated in the presence of human neutrophils"
FT CDS 324438..328229
FT /gene="orf19.4136"
FT /Ca19Contig="Ca19-10198|join(9617..11557,11559..13406)"
FT /synonym="orf19.11613, IPF9818.2, IPF14987.3, Contig4-
FT 2911_0009, Contig4-2911_0010, orf6.2611, orf6.5242,
FT orf6.5240, CA3093, CA6319, orf19.4138, orf19.4139"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21; not
FT essential for viability"
FT CDS complement(328285..329793)
FT /gene="orf19.4142"
FT /Ca19Contig="Ca19-10198|complement(join(14417..14974,13462.
FT .14415))"
FT /synonym="orf19.11617, orf19.11618, IPF9821.2, IPF19600.1,
FT IPF19601.2, IPF9821.5f, Contig4-2911_0007, Contig4-
FT 2911_0008, orf6.5238, orf6.5237, orf6.717, CA3092, CA3091,
FT orf19.4141"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21;
FT decreased transcription is observed upon fluphenazine
FT treatment"
FT CDS 330482..330910
FT /gene="orf19.4143"
FT /Ca19Contig="Ca19-10198|15663..16091"
FT /synonym="orf19.11619, IPF18385.1, IPF9823.2, Contig4-
FT 2911_0006, orf6.5236, orf6.718, CA3090"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(331012..332823)
FT /gene="orf19.4144"
FT /Ca19Contig="Ca19-10198|complement(16193..18004)"
FT /synonym="orf19.11620, IPF9825.2, IPF19173.1, Contig4-
FT 2911_0005, orf6.5235, orf6.719, CA3089"
FT /remarks="Predicted ORF in Assemblies 19, 20 and 21"
FT CDS complement(333155..336412)
FT /gene="orf19.4145"
FT /Ca19Contig="Ca19-10198|complement(18336..21593)"
FT /synonym="orf19.11621, IPF9826.2, IPF19172.2, Contig4-
FT 2294_0005, Contig4-2911_0001, orf6.236, orf6.5234,
FT orf6.720, CA3088"
FT /remarks="Predicted zinc-finger protein of unknown
FT function"
FT CDS 338300..338620
FT /gene="orf19.4146"
FT /Ca19Contig="Ca19-10198|23481..23801"
FT /synonym="orf19.11622, IPF14903.1, IPF19380.1, Contig4-
FT 2294_0001, orf6.235, orf6.5233, CA3087"
FT /remarks="Protein described as a core snRNP protein;
FT induced upon adherence to polystyrene"
FT CDS complement(338769..340319)
FT /gene="orf19.4147"
FT /Ca19Contig="Ca19-10198|complement(23950..25500)"
FT /synonym="orf19.11623, IPF14902.2, IPF28513.1, Contig4-
FT 2850_0001, orf6.234, orf6.5232, CA3086"
FT /remarks="Glutathione reductase; transcriptionally
FT